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EXPOSURE OF NERVOUS SYSTEM CELLS TO POLYCHLORINATED
BIPHENYLS (PCBs), RESULTS IN ALTERATIONS OF
NEUROTROPHIC FACTOR EXPRESSION

Gordon H. Gurley, Ph.D.
Western Michigan University, 2006
Toxic insult by PCBs results in learning and memory deficits in humans.
Alterations in expression of neurotrophic factors (NF) and/or their receptors have
been linked to changes in learning and memory. How PCBs affect cognition is not
known. We suggest that PCBs affect cognition by altering NF expression.
We exposed cultured C6 rat glioblastoma cells (an astrocyte cell-line) to
medium containing PCB (Aroclor 1254 (lOppm)). Control cells were treated with
dimethyl sulfoxide (DMSO) or regular medium. Enzyme-linked immunosorbent
assays (ELISA) were used to determine glial cell-line derived neurotrophic factor
(GDNF) and nerve growth factor (NGF) concentrations in all samples. We also
assayed for intracellular NF from cell lysates.

Real-time RT-PCR was used to

determine GDNF mRNA levels and pharmacological assays were utilized to
investigate the role of protein kinase C (PKC) in the signaling pathway by which
PCBs may exert their effect on GDNF gene expression. In addition we subjected rats
to dietary exposure o f PCBs and lead and assayed their brain tissue for NF protein
content.
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Results show that PCBs increased both synthesis and release of GDNF and
increased secretion of NGF in glial cells. We determined that PCBs use the PKC
signaling pathway in their effect on GDNF expression in glial cells. Rats exposed to
PCBs had reduced NF protein in their brains and there was a negative correlation of
brain GDNF protein levels to blood lead levels (BLLs) in the lead exposed animals.
Our data show that exposure of nervous system cells to toxins such as PCBs
and lead, alters NF expression and hence offers a basis whereby these neurotoxins
may alter neural plasticity leading to compromised cognition.
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CHAPTER I
GLOBAL INTRODUCTION

The objective o f this research was to investigate how neurotrophie factor
expression is affected by neurotoxic insults. We studied the effects of two wide
spread environmental toxins. Polychlorinated Biphenyls and Lead (Pb) on the
expression o f nerve growth factor (NGF), brain derived neurotrophic factor (BDNF)
and glial cell line-derived neurotrophic factor (GDNF). Numerous studies support
the idea of a critical association of altered NF with deficiencies in neural functions,
including learning and memory. It is also well established that toxins like PCBs
affect learning and memory in animals as well as humans. This study therefore, was
significantly driven by the suspicion that toxins like PCBs and lead may mediate
some o f their adverse effects on learning and memory by altering NF expression.
Our in vitro studies utilized the C6 glial cell-line. The in-vivo studies were
performed in rats. The following sections therefore, offer general and in some cases,
brief backgrounds on: NFs, glial cells, PCBs and lead.
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Historical Overview of Neurotrophic Factors
NFs are a group o f proteins whieh are able to promote differentiation, and
survival of both central nervous system and peripheral neurons. Generally these are
small soluble proteins with molecular weights ranging from 13 to 24 Kilodaltons and
are often active as homodimers (Lipton and Kalil 1995)
The first NF to be discovered was NGF, discovered in the late 1940s. It
belongs to a subset of NFs called neurotrophins which include Neurotrophin 3, Brain
Derived Neurotrophie Factor, and Neurotrophin 4/5 (NT-3, BDNF, NT-4/5)
(Heerssen and Segal 2002, Levi-Montalcini 1987). Rita Levi-Montalcini, an Italian
biologist and Stanley Cohen an American biochemist shared the 1986 Nobel Prize in
Physiology or Medicine largely for their discovery of, and work on, NGF.
The serendipitous discovery of NGF has its history in work done in the lab of
Viktor Hamburger. Elmer Bueker, a former student of Hamburger, reported the result
of an experiment involving the grafting o f mouse sarcoma 180 into the body wall of
3-day old chick embryos. Histological observation of the embryos fixed 3- 5 days
later, revealed that sensory fibers emerging from adjacent dorsal root ganglia had
gained access into the tumor. The experimenter concluded that there was some
unique histochemical property of the fast growing mouse sarcoma whieh offered a
favorable field for the growth of sensory fibers. In addition, the sarcoma tissue
environment induced enlargement of the exposed ganglion. This led to continuous
in-vivo and in-vitro investigation by Hamburger and Levi-Montalcini using in
addition to mouse sarcoma 180 another, sarcoma 37. Not only did this unknown

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3

tumor factor, humeral factor—as they then called it, induce sensory fiber growth but
sympathetic as well. Sympathetic fibers tended to grow in large bundles. The factor
also caused dense innervation of blood vessels with fibers protruding into the lumen
and in some cases to the extent of obstructing blood flow. In experiments where the
tumors were inserted next to embryonic ganglion, but separated by a membrane, the
trophic effect was still produced, indicating that the factor was dissolvable and
diffusible. Sensory ganglia in the presence of the growth promoting extract caused
halos o f nerve fiber outgrowth m vitro.
Later Cohen stumbled upon an even more potent source of this growth factor.
He had isolated from the two tumors a nucleoprotein fi-action containing the nerve
growth promoting activity (Cohen et al. 1954). He used snake venom, a source of
phosphodiesterase, to study the mechanism by which the extracted nucleoprotein
worked. During the classical halo experiments, by pure chance he discovered—not
only did the venom seem to enhance the nerve growth promoting activity of the tumor
fractions, but even minute quantities of the venom itself possessed the ability. From
the snake venom Cohen isolated and purified a non-dialyzable, heat-labile substance
with the nerve growth promoting propensity that he termed nerve growth factor
(NGF). Microgram quantities of this identified protein (of approximate molecular
weight 20,000) mimicked the effects of the two mouse sarcomas on sensory and
sympathetic ganglia and fibers. The researchers continue their search for NGF in
several non-sarcoma tissue types. Cohen reasoned that the salivary gland of mouse,
the homologue body part with the source o f snake venom, should be a good source of
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the factor. His intuition paid off with dividend. From the sub-mandibular gland of
male mouse, Cohen identified and purified salivary NGF, a protein molecule with
molecular weight of 44,000. Salivary gland turned out to be a greater source of NGF
than venom (Cohen et al. 1954). The primary structure of male mouse sub-maxillary
NGF was determined in 1971 as a result of its successful sequencing (Bradshaw
1978). This led to the identification of its cDNA and subsequent cloning from various
animal sources including human. The clones were highly homologous to the mouse
NGF (Scott et al. 1983, Ullrich et al. 1983)
The discovery of NGF opened up the “flood-gates” for the search and
identification of other such factors. The discovery of other members of the
neurotrophin family was quickly forthcoming. Three of them, BDNF, NT-3, and NT4 also called NT-5, were characterized in mammals. BDNF was first purified from
pig brain (Barde et al. 1982) and its gene was later cloned by Liebrock and colleagues
(Liebrock et al. 1989: in Lindsay et al. 1996). By comparing conserved sequences of
NGF and BDNF, clone homologues were obtained and used to identify NT-3, and
NT-4/5 (Lindsay 1996). These four—NGF, BDNF, NT-3 and NT-4/5 are derived
from a common ancestral gene, are similar in sequence and structure and therefore
were collectively named neurotrophins (Huang and Reichard 2001). Two additional
neurotrophins, NT-6 and NT-7 are related to NGF but unlike the afore-mentioned
neurotrophins, whose genes have been found also in reptiles, amphibians and
mammals, NT-6 and NT-7 have been found only in fish (Hallbddk et al. 1998). The
discovery and cloning of NT-6 from the teleost fish Xiphophorus (Gotz et al. 1994),
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and NT-7 from zebra fish (Nilsson et al. 1998), was reported in 1994 and 1998
respectively.
If the quote; “The discovery of molecules with therapeutic value often occurs
by chance rather than by purposeful experimentation” is true in the case of NGF the
first neurotrophic factor to be discovered, it is also true for a more recent NF that is
not a member of the neurotrophin family, that being GDNF. Discovered in 1993 as a
result of the suggestion that glia secrete factors that influence growth and
differentiation of specific neurons, GDNF was the first member identified of a new
family of NFs (Bohn 1998). GDNF is also reported to be a distant member of the
transforming growth factor-P (TGF-P) superfamily of proteins (Yajima et al. 1997).
Just prior to the discovery of GDNF, Schubert and colleagues performed a study
aimed at identifying cell-specific proteins in the nervous system. The study utilized a
technique called two- dimensional electrophoresis, to compare expressed proteins by
various glial and neuronal cell-lines. The result was astonishing. The gel patterns of
intracellular proteins o f the cell lines were almost identical, whereas those of the
secreted proteins were remarkably different. This lead to the idea o f investigating
secreted protein fraction of a cell line as a good source for the identification of cellspecific proteins. This approach seemingly had the potential for revealing novel
molecules with possible trophic effects on different cell types. Jurgen Engele, a
postdoc at the time in Bohn’s lab, pursued the concept despite the unavailability of
the now advanced molecular tools. He cultured dopaminergic (DA) neurons, some
glial tumor cell lines and pheochromocytoma cells (PC 12), a neuron cell line. Using
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burdensome bioassays, he screened for protein fractions that promoted varied trophic
activities o f the DA neurons. These growth references included the following:
neuronal survival, degree of neurite outgrowth, and extent of high-affinity DA uptake.
He found that all the glial cell lines secreted proteins that had effects on DA growth
activity but the PC 12 cells did not (Bohn 1998). Utilizing these bioassays, Lin and
co-workers (Lin et al. 1993) isolated from one of the glial cell lines, B49, a
glycoprotein of 134 amino acids with intense DA neurotrophic propensity, called
GDNF. GDNF was found to have greater potency than any previously discovered DA
neurotrophic factors (Bohn 1998).
In December o f 1996, Kotzbauer and colleagues reported their discovery of
yet another NF, a member of the GDNF family called Neurturin (NTN), also a distant
member o f the (TGF)-P superfamily (Kotzbauer et al. 1996). While investigating
whether factors other than NGF supported sympathetic neuronal survival in culture,
the researchers discovered that conditioned medium of Chinese hamster ovary cells
contained long-term survival of superior cervical ganglion (SCG) sympathetic
neurons activity in culture. This SCG survival-promoting factor was thermo-stable
and trypsin sensitive. This molecule had the attributes of a peptide but it was not
affected by neutralizing antibodies against NGF and based on its chemical properties
it was distinguishable from any other known neurotrophins. Yet, it promoted the
survival o f 100% of neurons supported by NGF. Sequencing of this molecule revealed
it to be a new factor whose sequence was then used to clone mouse complementary
DNA (cDNA), subsequently yielding mature protein upon proteolytic cleavage of the
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pro-protein. It was found that mature NTN of humans exhibits 91% homology with
that of mouse NTN and that its amino-acid sequence shares approximately 42%
similarity with mature GDNF (Kotzbauer et al. 1996).
In February of 1998, Persephin another member of the GDNF family was
identified. Persephin did not bind receptors known to bind GDNF and NTN, so it was
suggested that persephin utilizes additional or different receptors to GDNF and NTN.
Persephin however, is about 40% identical to the mature regions of GDNF and NTN
(Milbrandt et al. 1998).
The discovery of a forth member of the GDNF family called Artemin was
reported just 9 months subsequent to the report of Persephin (Baloh et al. 1998).
Artemin is almost identical to another GDNF family member reported to have been
cloned and characterized just soon after the reporting of Artemin, called Enovin
(Masure et al. 1999). Interestingly, although Enovin is reported by its researchers to
be very similar to but different from Artemin, the OMIM gene database lists it to be
synonymous to Artemin (OMIM 2005).
All four/ five aforementioned GDNF family members are distantly related to
the members of the TGFp family o f growth factors (Lin et al., 1993; Buj-Bello et al.,
1995; Hoger et., 1998) cited in (Soler et al. 1999). The list o f neurotrophic factors has
not been exhausted, furthermore, at the rate at which discovery and development in
this field has been growing, future identifications of novel NF will be accompanied by
very little surprise.
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Molecular Structure and Signaling Mechanism of Neurotrophic Factors
Neurotrophins are relatively small homodimeric polypeptides generally of
about 120 amino acid residues (Persson and Ibanez 1993). They are closely
structurally related. For example, the conserved sequences of the NGF family were
studied from varied vertebrates—human, rat, chicken, viper, xenopus, salmon and
ray. It was found that BDNF, NT-3 and NT-4/5 all share about 50% sequence identity
(Hallbook et al. 1991). The neurotrophins generally interact with two common
families of receptors expressed by the cells they target. One receptor they bind to
with high affinity, the Trk family of protein tyrosine kinase receptors. The other
receptor type they bind to with low affinity, the p75 neurotrophin receptor (p75 ^ ^ ).
The high affinity NGF receptor subsequently classified as the proto-oncogene Trk, a
family o f tyrosine kinase protein (Martin-Zanca et al. 1989), was first detected by
Hosang and Shooter (1987) while working on cell surface receptor proteins of PC 12
cells that responded to NGF. They detected a 130,000 Dalton protein that slowly
releases NGF and is internalized at 37°C (Alonzo 1991). Each neurotrophin member
can influence specific biological activities by preferential binding to ligand specific
receptors of the Trk family. Thus cell types such as sympathetic neurons, nerve fibers
of the dorsal root ganglion of the spine, and cholinergic neurons of the basal forebrain
all express the TrkA receptor which specifically binds NGF (Fagan et al. 1996).
BDNF andNT-4/5 preferentially bind TrkB (Klein et al. 1989), which is extensively
expressed in both the peripheral and central nervous system, in cells such as spinal
motor neurons and nodose ganglion sensory neurons (Meakin and Shooter 1992). NT-
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3 interacts with TrkC which is expressed by large sensory and motor neurons of the
spine and noradrenergic neurons of the locus coerulus (Barbacid 1994, Numan et al.
1998). NT-3 to some extent is promiscuous and will also bind, albeit with less
affinity, both TrkA and TrkB (Barbacid 1994, Rydén and Ibanez 1996).
The low affinity neurotrophin receptor, p75, was first identified as a
membrane protein that can bind NGF (Radeke et al. 1987), but it was later shown to
be capable of binding all o f the neurotrophins (Rodriguez-Tabar et al. 1992, Ryden et
al. 1995). It was originally suggested that p75

functioned as a positive regulator

of Trk, probably based on evidence of lost nociceptive and tbermosensative sensory
neurons in p75 knockout mice (Lee et al., 1992 Bamji et al. 1998). It was later shown
however that p75

can signal on its own and has so-called binding death domains

that trigger the cell death pathway of neuronal as well as glial cells (Bamji et al. 1998,
Murray et al. 2004). In general neurotrophin receptors act as sensors that relay
various extracellular and intracellular signals in the cells they target. These signaling
activities account for the unique effects neurotrophins have on behavior and bigherorder activities (Chao et al. 1992). A model for the NGF family receptor activation is
illustrated by the following figure 1.1
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TrkA
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=
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Figure 1.1. Model of Trk and p75 Receptor Activation. Neurotrophin binding
results in dimerization of each receptor. Neruotrophins bind selectively to specific
Trk receptors, whereas all neurotrophins bind p75. TRk receptors contain
extracellular immunoglobin G (igG) domains for ligand binding and a catalytic
tyrosine kinase sequence in the intraeellar domain. Each receptor activates several
signal transduction pathways. The extracellular portion of p75 contains four cysteinerich repeats, and the intracellular part contains a death domain. Neurotrophin binding
to p75 receptor mediates survival, cell migration and myelination through several
signaling pathways. Interaction between Trk and p75 receptors can lead to changes in
binding affinity for neurotrophins.
Figure and legend taken from (Chao, 2003)
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The GDNF family of neurotrophic factors, induce their effeets through
multicomponent receptors eonsisting of a family of receptors called the Ret receptor
kinases, in combination with glycosylphosphatidyl inositol (GPI)-Iinked receptors
called GFRas. Like the Neurotrophins and their receptors, these proteins, though
they share close sequence homology, each signals through their speeific receptor. In
the case of these proteins however, each of these specific receptors then interacts with
a common receptor, the RET receptor tyrosine kinase (Remy et al. 2001). RET
activates several intraeellular signalling cascades, which regulate cell survival,
differentiation, proliferation, migration, ehemotaxis, branching morphogenesis,
neurite outgrowth and synaptic plasticity (Sariola and Saarma 2003). Figure 1.2
illustrates the basic signaling pathways of this family of NFs:
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Figure 1.2. GDNF-Family Ligands and Receptor Interactions. Homodimeric glial cell
line-derived neurotrophic factor (GDNF)-family ligands (GFLs) activate RET tyrosine kinase
(TK) by first binding their cognate GDNF-family receptor-g(GFRa) receptors. Arrows
indicate the preferred ligand-receptor interactions that are known to occur physiologically in
vivo. GFRgproteins are attached to the plasma membrane by a glycosyl phosphatidylinositol
(GPI) anchor and are predicted to have three globular cysteine-rich domains (1,2,3) (except
for GFRa4, which has only two), joined together by less conserved adaptor sequences 1.
GFLs bind mainly to the second domain of GFRgreceptors, which is also crucial for RET
binding. Although the extracellular domain of RET interacts with all four GFL GFRg
complexes, the regions of RET that are involved in these interactions have not been
delineated. Binding of Ca2+ ions to one of the four extracellular cadherin-like domains of
RET is required for its activation by GFLs87. Four tyrosine residues in the RET intracellular
part (Tyr905, TyrlOlS, Tyrl062 and Tyrl096; red balls) serve as docking sites for different
adaptors. One of them (Tyrl096) is in the carboxy-terminal end of the long isoform of RET
(grey). Membrane rafts are shown in yellow. ARTN, artemin; NRTN, neurturin; PSPN,
persephin.
Figure and legend takenfrom (Airaksinen and Saarma 2002)
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Reiationshin Among NF. Nervous System Cells and Cognition
Neurotrophic factors are important for the growth of neurons and for
regulation of phenotypic expression during development. Several critical aspects of
the ontogeny of neurons for example—determination of neuronal population, neurite
branching and synaptogenisis, and synaptic plasticity in adults are regulated by NFs
(Sariola and Saarma 2003). Most neurons require a sustained supply of these trophic
factors throughout their lifetime for their normal maintenance and for recovery from
nervous system injury in the adult organism. NFs have been shown to be important
regulators of learning and memory. Results of recent studies suggest that blockade of
NGF effects in the brain results in impaired learning performance (Van der Zee 1995),
while administration of NGF enhances learning performance (Fiore et al. 2002,
Lipinski et al. 1995).
Generally, studies on the mechanism of learning and memory, have focused
on activities of the hippocampus in animal models such as mice and rats, and the
hippocampus is widely accepted to play a vital and pivotal role in memory (Broadbent
et al. 2004, Kumaran and Maguire 2005, Wesierska et al. 2005). The trend o f studies
investigating the effects of NFs on learning and memory therefore, has been on their
effects on hippocampal activities. One study reported that their results indicate a role
for NGF acting through its TrkA receptor on two proteins called choline acetyl
transferase (ChAT) and vesicular acetylcholine transferase (VAChT) in contextual
memory consolidation (Woolf et al. 2001). Mice with a disruption in one of their
alleles for NGF {ngf+l-) was shown to have reduced NGF mRNA and protein in the
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hippocampus. This was associated with shrinkage and loss of basal forebrain
cholinergic neuron and a decrease o f cholinergic innervation of the hippocampus. The
changes in these NGF-mutant mice were accompanied with measurable deficits in
learning and memory. Administration o f NGF effectively corrected the deficits in
size of cholinergic neurons and the density of cholinergic innervation of the
hippocampus (Chen et al. 1997). Rattiner and colleagues reported that Long-term
potentiation (FTP) within the hippocampus and hippocampally-dependent behaviors
have been the primary models for examining the role of BDNF in learning and
memory. Both morphological and chemical changes to synaptic organization are
most likely involved in the process o f learning and memory (Rattiner et al. 2005). It
has been shown in in-vitro and in-vivo studies that BDNF modulates hippocampal
FTP (Fee et al. 2005, Messaoudi et al. 2002). Several studies also have shown that
neurotrophins induce morphological changes in dendritic spines and synaptic
connections in brain regions associated with learning and memory (Gaiarsa 2004,
Tyler and Pozzo-Miller 2003, Wirth et al. 2003).
Glial cell line-derived neurotrophic factor (GDNF) is noted for its potent
neuroprotection of mid-brain dopaminergic (DA) neurons (Horger et al. 1998, Wang
et al. 2002, Winkler et al. 1996). GDNF also promotes the re-growth and survival of
DA neurons damaged by neurotoxins in-vitro. The neuroprotective and neuro-repair
properties of GDNF, highlights it as a favored therapeutic candidate for Parkinson’s
disease. Parkinson’s disease results from degeneration of midbrain nigral DA
neurons that innervate the striatum (Kirik et al. 2000, Fin 1996, Patel 2004). Other
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GDNF family ligands—neurturin, artemin, and persephin all maintain several
neuronal populations in the central nervous system. These NFs also support the
survival and regulate differentiation of several peripheral nerve cells, which include
sympathetic, parasympathetic, sensory and enteric neurons (Sariola and Saarma

2003^
Studies in mice in which GDNF expression is lowered via gene knockout,
indicate that low levels of GDNF in the central nervous system are associated with
impaired learning performance (Gerlai et al. 2001). In a study investigating the
effects of GDNF on progenitor cell proliferation and differentiation in the
hippocampus, (a site that supports adult neurogenesis) GDNF significantly increased
cell neurogenesis by 78%. The effects of GDNF on the hippocampus are potentially
important in memory and learning processes (Chena et al. 2005).

In-vitro Models Utilized
C6 Glial Cells
Glial cells are a source of NFs in the brain. There are 10 - 50 times as many
glial cells within the brain as neurons. They make up 90% of hrain cells (Miller et al.,
2003). Glial cells, referred to simply as glia were discovered in 1891 by Santiago
Ramon y Cajal, a Spanish neuroanatomist. They are non-neuronal cells that nourish,
support, and myelinate the nervous system and take part in its signal transmission.
Glia can be divided into two main groups—microglia and macroglia. Microglia
scavenge and engulf central nervous system (CNS) debris, in essence they are
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macrophages. Macroglia o f the CNS consist of: Astrocytes, which are the most
abundant glial cells, Oligodendrocytes, Ependymal cells, and Radial glia. Schawann
cells are glia of the peripheral nervous system (PNS). They have a similar function as
oligodendrocytes. That is, to provide myelination to axons of neurons. Each of the
previously listed types o f glia has special functions in the nervous system (Wikipedia
Contributors (2005)-a)
Until recently, glial cells have been thought to be important only as integral
support cells of the nervous system, but this concept has changed since it has been
recently shown that glial cells play a role in synapse formation. Astrocytes in
particular are believed to actually ‘instruct’ neurons to make synapses (Miller et al.,
2003). Some researchers reported that although neurons can form synapses without
glia, they may require glial derived cholesterol to form high numbers of efficient
synapses, suggesting glia as a source for synaptogenesis-promoting signals (Mauch et
al., 2001; Pfrieger et al., 2002). Glial cells play important roles in the immune system
including, inflammatory and cytotoxic responses (Cheeran et al. 2003, Giri et al.
2004, Lee et al. 2000). Glial cells are also integral components of the blood brain
barrier (Vries et al. 1997). In fact, previous researchers believed that the blood brain
barrier was formed by glial sheets covering the brain capillaries (Dempsey and
Wislocki 1955). It was later found to be more accurately a functional barrier of
cerebral endothelial plasma membrane (Brightman and Reese 1969).
The C6 glial cell line is an astrocyte cell line derived from rat. Rat C6 cells
possess extensive chemical and functional analogy to normal rat astrocytes (Syapin et
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al. 2001). This cell line is widely used among the scientific community as a model
especially for the study o f response to toxic insult to the nervous system.

In-vivo Model
The in-vivo aspect of this study utilized as its model rats that were exposed to
PCBs at varying doses and duration o f exposure. Rodents such as rats and mice have
been used extensively as mammalian models for behavioral studies of learning and
memory. Different systems have been developed to test and measure levels of
cognition. The Morris water maze developed by neuroscientist Richard G. Morris in
1984 is one such study system. This system is used primarily to explore the role of
the hippocampus in the formation of spatial memories (Wikipedia contributors
(2005)-b). The radial arm maze developed earlier by Olton has been steadily
improved and has been used by collaborators in this study. Roegge and colleagues
also used the radial arm maze to explore retardation in cognition of rats exposed to
PCBs (Roegge et al. 2000).

Polychlorinated Biphenyls (PCB)
PCBs are persistent environmental bio-accumulative, widely distributive,
toxic, pollutants. They accumulate in food chains, especially in certain species of fish
and seafood collected in contaminated areas. (Altmann et al. 2001, Li and Hansen
1997, Rao 2000). PCBs are polychlorinated hydrocarbons and they occur as both
ortho (non co-planar) and non-ortho (co-planar) substituted molecular
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configurations. Based on all the chlorination patterns, there are 209 possible
congeners. The basic structure from which all possible congeners are obtained is
shown in figure 1.3.

m

m

m

m

Figure 1.3. The General Structure of PCBs. m, o and p represent chlorine
substitutions of the meta, artho and para respectively, (adapted from McKinny et al.,
1994)
Commercial mixtures of PCBs called Aroclors, which are made up of several
individual congeners, were manufaetured in the United States for almost 50 years.
They were produced for use as nonflammable dielectrics in electronic parts,
lubricants, plasticizers in caulking compounds, paints, adhesives and sealants,
vehicles for pesticide application, and pigment suspension agents in carbonless copy
paper. (Korrick and Altshul 1998, McKinney and Walter 1994). One of these PCB
mixtures, called Aroclor 1254, was the most commonly sold and is the one most
commonly found at contaminated sites (Tilson and Kodavanti 1997).
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A total of 1,598 hazardous waste sites have been proposed for inclusion on the
Environmental Protection Agency’s (EPA) list. In at least 500 of these, PCBs have
been identified and of these 499 are situated in the United States (HazDat, 2000 ).

Figure 1.4. The Frequency of Waste Sites with PCB Pollution. Taken from
HazDat 2000 in (ATSDR, 2000)

In our immediate vicinity here in Michigan USA, the Kalamazoo River has
been identified as a Great Lakes Area-Of-Concem and Superfund site due to historic
releases o f PCBs from de-inking operations at local paper mills (Beck 1998).
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Atmospheric Deposition
Atmospheric deposition is the transfer of pollutants from air to the earth’s
surface. The atmospheric pathway is significant since it is the pathway by which
many toxic substances capable of sustained presence in the environment long after
manufacture or use, are widely distributed. PCBs do not easily break down, and so
can travel long distances in the air before deposition via rain or snow into bodies of
water or on to land. Once the temperature is high enough, these toxic substances can
revolatilize back into the air and travel further. This cycling called the grasshopper
ejfect can occur numerous times, resulting in pollutants traveling to cooler and cooler
environments until temperatures are too low for revolatilization. Atmospheric
deposition has been shown to be a significant source of pollutants to the Great Lakes
and other water bodies. The grasshopper effect also called global distillation is the
reason why high levels of pollutants such as PCBs can be found in the cold Artie, far
away from cities and factories (EPA).

Possible Ways of Destroying PCBs
According to the EPA, many items containing PCBs can be appropriately and
safely destroyed in hazardous waste incinerators, since PCBs can be destroyed by
burning at 2400 °F. Two technologies are currently used for on-site destruction of
PCBs. One is by using plasma arc torches, which bum up to 10,000 °F . This method
is being used for many soils that are contaminated with large amounts of PCBs. The
other process is the use of bacteria—a bioremediation process that is used for rivers
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with large sediment concentrations of PCBs. Currently there are over 20 strains of
bacteria capable of using biphenyl exclusively as their source of carbon (EPA).

Health Perspective
Even though PCBs have been banned in the USA since 1977 they continue to
pose health problems because of their persistent presence in the environment and in
the tissue of exposed humans. PCBs are exceedingly toxic and have been shown to
cause health problems in humans even at low levels. The highest acceptable
concentration in fish—according to the EPA, is two parts per million. Human
exposure to PCB can be through inhalation (respiration), digestion, or through the
skin (dermal absorption) (EPA). They are lipophilic and are present in the fat of all
human populations. The skin and liver are particularly susceptible to PCBs and there
is controversy as to their “carcinogenisity”(ability to cause cancer). A major concern
has been that of PCBs’ ability to cross the placenta to affect prenatal infants as well as
to affect postnatal infants via the milk o f exposed mothers (Korrick and Altshul 1998,
McKirmey and Walter 1994). PCBs are amongst the environmental chemicals
capable of endocrine system disruption in animals and humans. The ability of PCBs
to mimic natural hormones explains a possible mechanism by which they interfere
with endocrine function. The structural shape of these compounds underlies their
molecular interactions with biological systems. The coplanar configuration of PCBs
phenyl rings and the “laterality” of chlorine atoms are important structural features
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governing biological binding affinity and toxic reactivity (McKinney and Walter
1994).
The incidences that arc probably most credited for sparking the international
concern for and health hazard awareness o f PCBs are the mass poisonings called
Yusho and Yu-Cheng. These occurred in Japan in i968 and central Taiwan in 1979,
respectively. These incidences were caused separately by ingestion of rice oil
contaminated with polychlorinated hydrocarbons including PCBs. Some of the more
noticeable symptoms included—pigmentation of nails, skin and mucous membranes,
increase eye discharge, acneform eruptions and feeling of weakness. One year after
the initial poisoning of the Yu-Cheng victims, blood PCB concentration was 3 - 1156
ppb. Five years after the Yusho incident PCB concentration in blood was 1 - 3 0 ppb
(Masuda 1985). Studies carried out on pregnant mothers with Yusho report that
babies from these women were bom with PCB unique abnormalities, which the
researchers called fetal PCB syndrome (EPS). The manifestations included: Dark
brown “CoCa-Cola color” skin pigmentation, gingivial hyperplasia, early emption of
the teeth (some actually bom with teeth), increased calcification of the skull and low
birth weight (Yamashita and Hayashi 1985).
A review article highlighted a study based on the Yu-Cheng children exposed
to PCBs in utero and by lactation that reported that these children had poor cognitive
development (Aoki 2001). According to Cynthia Washam, a team of researchers
from London and Taiwan reported in the July 2002 issue of The Lancet (Washam
2003), a weakened ability of males exposed two decades ago to PCB in the Yu-Chen
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incident, to father boys. The report indicated that 46% of children bom to young men
exposed in the oil disaster are males compared to a world average of 51-52%.
Women exposed in the same incident showed no abnormalities in sex ratio of their
offspring (Washam, 2003).
In 1989 the World Health Organization reported that contamination of breast
milk with PCBs and dioxins is higher in the Netherlands, Belgium, Germany and the
United Kingdom than in most other parts of the world (WHO, 1989 in (Schantz et al.
2003)). As a result the Dutch Government launched a longitudinal study known as
the Dutch PCB/Dioxin Study to investigate the possible adverse effects of exposure to
PCBs and dioxins and growth and development o f full-term infants. This study was
the first to apply congener-specific analytic techniques. More recent studies have had
the advantage of modem analytical methods and as a result congener-specific analysis
procedures are widespread and available. These advances in techniques and
toxicological knowledge have been instrumental in influencing a renewed risk
assessment process. Data from ongoing PCB studies assessing the mediators of
neurobehavioral outcomes in children are being published and as a result
incriminating evidence for PCB’s effects on neurodevelopment is significantly
increasing. Studies in Taiwan, Michigan (USA), New York (USA), Holland,
Germany, and the Faroe Islands have all reported negative associations between
prenatal PCB exposure and measure o f cognitive functioning in infancy or childhood
(Schantz et al. 2003).
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The studies described herein examined the effects of PCBs on the nervous
system, with an interest in effects on cognition. The nervous system has been shown
to be highly sensitive to the effects of PCBs. Epidemiological studies in humans have
demonstrated a variety of nervous system deficits associated with PCB exposure,
including alterations in function of the peripheral (Chia and Chu 1984) and central
nervous system (Jacobson and Jacobson 1997, Jacobson JL. et al. 1990). Impairments
in learning and memory have been documented both in young (Grand)can et al. 2001)
and older humans (Schantz et al. 2001) following environmental exposure to PCBs,
and in rats exposed to PCBs (Widholm et al. 2001). Developmental exposure to
PCBs has been associated with cognitive deficits in children. Experiments with
rodents have revealed impairments in learning tasks that involve the hippocampus
(Gilbert et al. 2000)
Although PCB exposure has been shown to alter a variety of intracellular
signaling processes in neurons, including calcium signaling, protein kinase C
signaling and neurotransmitter synthesis (Tilson and Kodavanti 1998), very little is
known concerning the mechanism by which PCBs affect learning and memory. The
risk to the developing nervous system posed by PCBs is difficult to asses due to a
general lack of information on mechanism/s by which PCBs induce neurotoxicity
(Howard et al. 2003). Furthermore, very little is known concerning effects of PCBs
on neurotrophic factor expression or effects (Angus and Contreras 1994, Angus and
Contreras 1995).
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At least three mechanisms of action by which PCBs appear to exert their
toxicity have been suggested: (1) reversible binding with specific molecular sites of
action, such as receptors, enzyme, etc., (2) irreversible covalent interaction between
PCB and target molecules—macromolecules such DNA and proteins, and (3)
accumulation of highly lipid-soluble, metabolically stable PCBs in lipid-rich tissues
or tissue compartments (McKinney and Walker, 1994). Being aware of the many
reported studies that established a relationship between NFs and the nervous system,
we studied the effects o f PCBs on NGF, BDNF and GDNF, utilizing both in-vitro and
in-vivo experiments, in an attempt to suggest an indirect mechanism by which PCBs
may cause alterations in the CNS that may lead to compromised cognitive abilities.

Lead
Despite the fact that Pb is one of the oldest (three millennia) known poisons,
and that there has been knowledge of its effects on children for over 100 years, its
exposure continues to be a major public health problem. As a result investigations of
the neurotoxicity of Pb still occupy an area of active research, and there have been
recent developments in the study o f its basic mechanism of action (Burger and
Gochfeld 2004, Lidsky and Schneider 2003)
Unlike PCBs, which are man-synthesized compounds, Pb is a common
element o f the geosphere, but its ubiquitous presence in the environment in
bioavailable forms is largely due to human activities (Rice, 1984,1996; Bellinger et
al., Payton et al., 1998; Laskey et al., 2000 in: (Burger and Gochfeld 2004) For
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example, between 1969 and 1971 an ore smelter in El Paso, Texas had discharged
1,116 tons of lead into the atmosphere. Subsequent analysis of soil and ‘house-holddusf Pb concentrations was conducted in areas close to smelters, and correlative
studies of blood lead levels (BLLs) in children and adults were performed. The
studies reported that Pb emitted by the smelter and deposited in soil and house-hold
dust, appear to be the major source of Pb absorbed by humans (Rosenblum et al.
1973). Since the 1970s lead has been deemed a ubiquitous contaminant with several
contributing “human responsible sources” such as Pb based paints and gasoline.
Within recent times however decreases in the use of leaded gasoline and lead-based
paints in the USA have resulted in reductions of lead exposure and BLLs (ATSDR
1999). Recent studies have lead to a greater awareness of health hazards posed by
lead toxicity at much lower BLLs than first expected. In 1971 “undue lead
absorption” referred only to BLLs equal to or greater than, 40 pg/dL. But several
Subsequent studies reported that BLLs much lower than 40 pg/dL adversely impacted
the health of children without causing overt symptoms (Matte and Falk 1997). For
example, one study reported lower cognitive test scores and higher teachers’ rating of
behavioral problems among children with higher dental lead levels but no history of
clinically overt lead poisoning (Needleman et al. 1979). Numerous other studies
report that in humans and primates, lead exposure at low or medium levels leads to
auditory, neurobehavioral, reproductive and systemic effects (Rice 1995) in: (Burger
and Gochfeld 2004). Although the relationship between lead exposure and cognitive
development has been a lively controversy among certain researchers (Burger and
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Gochfeld 2004), many studies agree that even at low doses, lead exposure can
produce serious adverse effects on the central nervous system of children and that
these effects can last for years.

Background Re-cap and Projection
In this background I provided the general account of the history, origin and
distribution o f certain environmental toxins, namely PCBs and lead, and their mode of
entry into Biological systems. An overview of the risks these pollutants pose and
several examples of past, present and fiiture health risks were highlighted. Since there
is significant evidence that both o f these toxins affect the central nervous system to
the extent of causing retardation in learning and memory, the present study was
oriented towards trying to understand possible relationship between these toxins and
other factors that promote, modify and maintain the integrity of the nervous system.
These factors are neurotrophic factors and hence an overview of their discovery,
classification, structure and biological functions were given. The objective of this
study was to investigate the effects of the studied toxins on the expression of these
neurotrophic factors and how such changes may allow room for speculations on how
toxins such as PCBs may indirectly affect cognition by their direct effect on
neurotrophic factors. An overview of the models—in-vitro and in-vivo used to
facilitate the investigations was given.
Following will be: a list o f the statistical methods used in this study; chapter II
which present the in-vivo investigations and findings relating to PCB exposure;
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chapter III which presents the in-vivo investigations and findings relating to lead
exposure; chapter IV which presents the in-vitro experimentations and findings and
finally chapter V which provides a global discussion as well as offer projections and
suggestions of further studies.

Statistical Methods
A one-way ANOVA was used to test differences from controls and each
ANOVA was followed by a post-hoc test to determine where differenees lie among
treatment groups. A two-way ANOVA was used to compare treatment levels and
duration followed by Student-Newman-Keuls method of Pairwise Multiple
Comparison. A linear regression was used, followed by Pearson Product Moment
Correlation, to test whether blood lead levels (BLLs) in exposed rats were predictors
of neurotrophic factor protein levels in their brains. Data are expressed as mean + or
± standard error of the m ean-"*" indicates statistical significant difference at P <
0.05 and “**” indicates statistical significant difference at P < 0.001. Other symbols
of specific meanings are displayed and defined on individual figures.
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CHAPTER II
THE EFFECTS OF POLYCHLORINATED BIPHENYLS (PCBs) ON
NEUROTROPHIC FACTOR (NF) EXPRESSION IN RAT BRAIN AND
POSSIBLE IMPLICATIONS IN COGNITIVE DEFICIENCY

Introduction
The aim o f the study presented in this chapter, was to determine whether
exposure to PCBs (A1254) Alters neurotrophic factor protein expression in the brains
of rats. The study also aimed at determining if A1254 induced alterations in NF
expression may be correlated to impaired performance in radial arm maze (RAM)
tests for spatial learning and memory.

PCBs
PCBs are polychlorinated hydrocarbons. Commercial mixtures of PCB
congeners, Aroclors, were manufactured in the United States for almost 50 years for
use as nonflammable dielectrics in electronic parts; in several products including:
lubricants, paints, and sealants; as vehicles for pesticide application, and as pigment
suspension agents in carbonless copy paper (Korrick and Altshul 1998, McKinney
and Walter 1994).
The nervous system has been shown to be highly sensitive to the effects of
PCBs. Epidemiological studies in humans have demonstrated a variety of nervous
system deficits associated with PCB exposure, including alterations in function of the
peripheral (Chia and Chu 1984), and central nervous system (Jacobson and Jacobson
1997, Jacobson JL. et al. 1990). Impairments in learning and memory have been
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documented both in young (Grandjean et al. 2001) and adult humans (Schantz et al.
2001) following environmental exposure to PCBs, and in rats exposed to PCBs
(Widholm et al. 2001). Developmental exposure to PCBs has been associated with
cognitive deficits in children.
At least three types of basic mechanisms of action by which PCBs appear to
exert their toxicity has been suggested: (1) reversible binding with specific molecular
sites o f action such as receptors, enzymes, etc., (2) irreversible covalent interaction
between PCB and target molecules, macromolecules such as DNA and proteins, and
(3) accumulation of highly lipid-soluble, metabolically stable PCBs in lipid-rich
tissues or tissue compartments (McKinney and Walker, 1994). Very little is known
however, concerning the mechanism by which PCBs affect learning and memory.
Little is also known about the effects o f PCBs on NF expression or effects (Angus and
Contreras 1994, Angus and Contreras 1995)

Neurotrophic Factors
NFs are integral and inevitable agents of the development and maintenance
of the nervous system. Several critical aspects of the ontogeny o f neurons for
example—determination of neuronal population, neurite branching and
synaptogenesis, and synaptic plasticity in adults are regulated by NF (Sariola and
Saarma 2003). Most neurons require a sustained supply of these trophic factors
throughout their lifetime, for their normal maintenance and for recovery from nervous
system injury in the adult organism.
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Because of the roles NFs play in synaptic plasticity (Elliott et al. 2001, Tyler et
al. 2002), it is assumable that agents affecting their homeostasis may also
inadvertently affect cognition. Many studies suggest that synaptic plasticity plays a
fundamental role in learning and memory (Abbott and Nelson, Johnston et al. 2003,
Rampon and Tsien 2000). “A change in the transmission efficacy at the synapse
(synaptic plasticity) has been considered to be the cause of memory”(Okano et al.
2000). Other studies demonstrate significant deterioration in spatial learning due to
disruption of mechanisms involved in synaptic plasticity (Saura et al. 2004, Sun et al.

2002).
NFs have been shown to be important regulators of learning and memory.
Results of previous studies suggest that blockade of nerve growth factor (NGF)
effects in the brain results in impaired learning performance (Van der Zee 1995),
Mice with a disruption in one allele for NGF (ng/F/-) were shown to have reduced
NGF mRNA and protein in the hippocampus. These changes were accompanied by
measurable deficits in learning and memory (Chen et al. 1997). Several studies also
have shown that neurotrophins induce morphological changes in dendritic spines and
synaptic cormections in brain regions associated with learning and memory (Gaiarsa
2004, Tyler and Pozzo-Miller 2003, Wirth et al. 2003).
GDNF is noted for its potent neuroprotection of mid-brain dopaminergic (DA)
neurons (Horger et al. 1998, Wang et al. 2002, Winkler et al. 1996). GDNF also
promotes the regrowth and survival of DA neurons damaged by neurotoxins in-vitro.
Studies in mice in which GDNF expression is lowered via gene knockout, indicate
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that low levels of GDNF in the central nervous system is associated with impaired
learning performance (Gerlai et al. 2001).

Hypothesis: PCBs may affect learning and memory by altering the expression of
neurotrophic factors
The previous overview highlighted a few of the many studies that implicate
PCBs as cognitive altering compounds. It also presented other studies that
established a relationship between altered NFs and reduced ability in learning and
memory. This study questioned therefore, whether a possible means by which PCBs
affect cognition is by altering NF expression. We therefore investigated the effects of
Aroclor 1254, a commercial mixture of PCBs, on NF protein levels in brains of rats
which had undergone learning and memory test (behavioral studies by Paris-Larson,
2004) following treatment with PCBs.

Methods and Materials
A1254 Treatment of Rats for NF Analysis (Experiment 11
Fischer Rats (7 weeks old) were allowed to feed ad-libitum for 7 days (short
term) or 84 days (long term) on a diet containing 10 ppm or 50 ppm Aroclor 1254
(Lot 124-191-B, obtained from Accustandard) or the control diet which was free of
PCBs.
To prepare the PCB treated diet, 2.0 kg o f Lab Diet 400 rat chow + 500ml
ethanol were added to a 1 gallon Nalgene jar. 20.0 ml of 1mg/ml or 2.0 ml of 10
mg/ml (for 10 ppm dose) or 100 ml of 1 mg/ml or 10.0 ml of 10 mg/ml (for 50 ppm)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

33

Aroclor 1254 stock solution was added. The mixture was shaken or rolled to allow
initial vigorous mixing. This was followed by four hours of fiirther mixing o f which
in the first hour each batch was shaken and turned every 15 minutes and then every 30
minutes for the remaining 3 hours. The food was then spread out in foil pans to dry in
hoods. Usually at least 48 hours of drying was needed for satisfactory evaporation of
solvents. Control food was mixed and dried the same way. Final food A1254 content
was determined by GC analysis of batch samples.

A1254 Treatment of Rats for behavioral Analysis rExperiment 2)
Eighteen male Fischer 144 rats (Charles River, Portage Ml) were obtained at
21 days of age and delivered to Haenicke Hall animal colony. Western Michigan
University. Western Michigan University animal colony was maintained at constant
20-22° C and 20-24% humidity under a 12 hour light/dark cycle. The animals were
housed singly in standard plastic hanging cages with free access to food and water.

Treatment
To prepare the Aroclor 1254 treated diet, 500 ml ethanol was mixed with 2.0
ml or 10 ml of lOmg/ml A1254 stock solution (for lOppm or 50ppm dose). This
solution was then poured over 2.0 kg rat chow (Purina). The rat chow/ Aroclor
mixture was placed on a rotary shaker for four hours and manually shaken every 15
minutes for the first hour, every half hour thereafter. The food was then placed in a
single layer in aluminum pans to dry for three days to allow complete evaporation of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

34

the ethanol. The Aroclor remains in the food and is spread evenly throughout. Each
dose was made in individual batches o f food. The control food was also soaked in
ethanol and dried, to eontrol for any unknown differences in smell or texture. The
animals were allowed to feed freely on the treated food for 28 days. On the 28* day
all food was replaced with standard Purina rat chow and free access to food was
continued for one week, at which time food was restricted to achieve 85% of free
feeding body weight.

Behavioral Study Procedure (All behavioral studies done by Paris-Larson—
student o f Lisa Baker PhD. Dept. Psychology Western Michigan University)

Habituation
A small handful of Fruitloops® were placed at the end of each arm of the
radial arm maze. The animals were plaeed in pairs in the center of the maze and
allowed to roam throughout the maze, with free access to the Fruitloops®. Each pair
was left in the maze for ten minutes. This procedure was repeated for three
conseeutive days.

Acquisition Phase
Training began on the day following the last habituation session. One
Fruitloop® was placed at the end of each arm o f the radial arm maze. Each animal
was placed individually in the maze and allowed to explore. Each animal was
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removed after all eight cereal pieces were eaten or 16 arms were entered. Training
sessions for each rat, occurred once a day for 28 days or until each group achieved a
mean of 80% accuracy for two consecutive days. An error was considered an entry
into a previously entered arm. Six measures were recorded or calculated during
acquisition; total time to complete the maze, latency to first bite of food, total number
of arm entries, repeat arm entries, number of entries made until first error, and number
of correct entries out of the first eight entries.

Delay Win-Shift Phase
In the second phase a delay win-shift procedure was utilized. A Fruitloop®
was placed at the end o f six randomly chosen, arms, while the other two arms were
blocked from entry by an adhesive index card. The blocked arms were randomly
chosen prior to each session for every rat. Each animal was removed from the maze
when all six Fruitloops® were consumed or 16 arms were entered. Three delays, 20
mintues, 2 hours, and 6 hours were established. After the given delay, each animal
was placed back in the maze and the previously blocked arms were now baited while
the other six arms were not baited. Each delay was tested for three consecutive days
(sessions). Each animal was removed from the maze when either both Fruitloops®
were eaten or 16 arms were entered. In this task, 100% accuracy was defined as one
entry into each of the two previously unbaited arms.
All data were recorded by two human observers and each session was
videotaped for further data collection. All entries were recorded in order of entry and
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each entry that resulted in food consumption was circled. The total number of arms
entered, repeated arm entries, number of entries until and error occurred, and the
number of correct entries out of the first eight were all recorded during or calculated
after each session. A stopwatch was used to record the latency, time until the first
Fruitloop® was eaten, and the total session time (Paris-Larson 2004).

Brain Collecting Procedure
The following procedure for obtaining rat brains for analysis was applied to all
experiments involving PCB exposed rats. The animals were sacrificed by CO2
euthanization and the brain from each animal was removed after decapitation with a
guillotine. Care was taken to remove and freeze the brains within 5 min post
sacrifice. Upon excision, the two cerebral hemispheres were immediately dropped
into tubes containing 2- methyl butane cooled on dry ice. Upon freezing, excess 2methyl butane was decanted and tubes were stored at - 80 °C. Half of a brain from
each animal was homogenized and processed for neurotrophic factor content, while
the complementary halves were cryostat sectioned for immunohistochemistry.

Brain processing for ELISA
Each hemisphere processed for NF quantitative analysis was weighed and then
crushed in a polythene envelope by hammering on an aluminum plate cooled with dry
ice. The resultant powder was put into a glass homogenizer and homogenized in 4ml
o f processing buffer (See appendix for buffer recipe), on wet ice. The homogenate
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was transferred to centrifuge tubes and spun at 2400 rpm, for 30 min, at 4 ”C. The
supernatant was collected and stored at -20 °C.

Enzvme-Iinked Immunosorbant Assay (ELISA)
ELISA was used to determine GDNF, NGF and BDNF protein content in the
supernatant obtained from each treated group. For NGF and GDNF analysis, antiNGF or GDNF, diluted in PBS, was added to 96 well plates, which were sealed and
allowed to incubate overnight. PBS was also used to wash plates between treatments.
Plates were blocked with 1% BSA for 1 hour and incubated for 2 hours with protein
standards and samples. Anti-NGF or anti-GDNF conjugated to biotin was diluted in
Tris Buffered Saline (see appendix for recipe) containing 0.1% BSA and 0.3%
Tween-20 and was added to plates for two hours of incubation. Streptavidin HRP
(Pierce) was added to plates followed by a 20 min incubation period. After washing
off unbound HRP, the color reagent (tetramethyl benzidine dissolved in phosphate
citrate buffer) was added. At fiill color development, the reaction was stopped with
0.1 M phosphoric acid and plates were scanned at 450 nm wavelength using a
microplate scanning spectrophotometer (Bio-Tek Instruments). The average
absorbance from each column of samples assayed in quadruplicates was calculated
and NF concentration was extrapolated from a log standard curve. For BDNF we
used ELISA kits from (Promega Coperation) and followed the manufacturer’s
protocol. All NF protein values were normalized to brain weight.
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Results

Effects of PCB on NF Levels in Rat Brains
Short Term (7 days exposure)
We determined the levels of NGF and GDNF protein in the brains o f rats
exposed to PCB in their diets. Twelve animals (4 rats per treatment group) were
exposed for 7 days to Oppm, lOppm and SOppm, respectively, and then sacrificed.
One cerebral hemisphere from each animal was processed and NF protein content was
determined by ELISA. The results showed significant reduction of both NGF and
GDNF protein content in the brains from animals subjected to acute PCB exposure
compared to that in controls (Figure 2.1a and 2. lb.).

GDNF protein levels in brains of rats
exposed to A1254 for 7 days

NGF protein levels in brains of rats
exposed to At254 for 7 days
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(b)Treatement groups—A1254 exposure
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Figure 2.1. NGF and GDNF Protein Levels in Brains of Rats Exposed for 7 Days
to 0,10, or 50 ppm A1254 in Their Diets. The brains were removed and processed
for determination of neurotrophic factor protein. The results showed that the A1254
exposed animals had significantly lower levels of both NGF and GDNF in their brains
than control animals (*). The higher dose group had lower levels of NGF and GDNF
than lower dose group (#). Statistical analysis used: 1-way ANOVA followed by
Dunnette post hoc. * = P < 0.05, ** = ? < 0.001.
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Long Term (84 days exposure)
Rats were treated in the same manner as the short term exposed rats, except
they were exposed for 3 months. The NF protein content of the brain homogenate
from these animals was determined by ELISA, as previously described. Results
showed that both A1254 exposed groups of rats had significantly less GDNF in their
brains compared to control rats. Long term treatment of rats with A1254 had no
effect on NGF protein levels, figure 2.2a and 2.2b.

GDNF protein levels in brains of rats
following 84 days of exposure to A1254

NGF protein levels in brains of rats
following 84 days of exposure to A1254
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Figure 2.2. NGF and GDNF Protein Levels in Brains of Rats Exposed for 84
Days to 0,10, or 50 ppm A1254 in Their Diets. The brains were removed and
processed for determination of neurotrophic factor protein content. The results
showed that the A1254 exposed rats had significantly lower levels of GDNF but no
changes in NGF in their brains. Statistical analysis used: 1-way ANOVA followed by
post hoc. * = significantly different from controls. P < 0.05.
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Comparison of Short Term to Long Term A1254 Exposure
A comparison of the effect of A1254 on NF protein expression in the brains of
rats exposed for 7 days or 84 days, showed a difference in response based on the
period of exposure, especially for the 50ppm exposed groups. The differences
between the means of the control groups and the treated groups for 7-days exposed
animals was significantly greater than that o f the 84-day exposed animals, as
illustrated by figures 2.3a and b.

Percent of Control NF Protein Levels in Rat Brains Following 7 and 84
Days of Exposure to A1254
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-
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Figure 2.3. Changes in NGF and GDNF Protein Content in Brains of Rats
Treated with A1254 for 7 Days (Short-Term), VS 84 Days (Long-Term). Results
show a decrease in the effect of A 1254 (% change from control) on NGF and GDNF
protein levels at the 5Oppm exposure level. A similar trend is observed, for NGF low
dose but not GDNF low dose. Statistical procedure: two-way ANOVA followed by
Student-Newman-Keuls post hoc.
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Result on NFs from Behavioral Groups

NF protein content was also measured in brains of rats which had undergone
behavioral tests following A1254 exposure. Rats were given A1254 in their diet for
28 days followed by a recovery period of 7 days before behavioral studies
commenced. They were subjected to the radial arm maze test to determine the effect
of PCBs on learning and memory—an exercise lasting 5 weeks, resulting in a total of
6 weeks recovery from A1254 exposure. At the conclusion of the behavioral
experiments, the rats were euthanized and their brains were excised for determination
of NF content.
The results indicated that the A1254 exposed groups of animals had
significantly lower levels o f NGF, BDNF and GDNF protein in their brains, compared
to non-exposed animals (Figures: 2.4, 2.5, and 2.6). There were no dose-dependant
differences in NGF and GDNF protein content. The BDNF results however, showed
a dose response difference where the 1Oppm A1254 caused a significant decrease in
BDNF protein while the 5Oppm exposure level did not. Moreover, the 5Oppm A1254
exposed group of rats had significantly higher BDNF protein in their brains compared
to the lOppm A1254 exposed rats (figure 2.5).
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Figure 2.4. NGF Protein Levels in Brains of Rats Exposed to A1254 for 28 Days.
Rats were exposed for 28 days to 0, 10, or 5Oppm A1254 in their diets, followed by 6
weeks of A1254-free diet. Animals were then euthanized and their brains were
processed for determination of NGF protein content. The results showed that the
A1254 exposed rats had significantly lower levels of NGF protein in their brains.
There was no significant difference between high and low dosage groups. Statistical
analysis used: 1-way ANOVA followed by a post hoc. * represents P < 0.05, N = 6.
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Figure 2.5. BDNF Protein Levels in Brains of Rats Exposed to A1254 for 28
Days. Rats were exposed for 28 days to 0, 10, or 5Oppm A1254 followed by 6 weeks
of A1254-free diet. Animals were euthanized and their brains were processed for
determination of NGF protein content. The results showed that the lOppm A1254
exposed rats had significantly lower levels of BDNF protein in their brains. The
5Oppm exposed group had higher levels of BDNF than the lOppm exposed group but
was not different to controls. Statistical analysis used: 1-way ANOVA followed by
post hoc. P < 0.05, * = sig. difference from controls and # = sig. difference between
exposed groups. N = 6.
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Figure 2.6. GDNF Protein Levels in Brains of Rats Exposed to A1254 for 28
Days. Rats were exposed for 28 days to 0, 10, or 5Oppm A1254 in their diets
followed by 6 weeks of A1254-ffee diet. Animals were then euthanized and their
brains were processed for determination o f GDNF protein content. The results
showed that the A1254 exposed rats had significantly lower levels of GDNF protein
in their brains. There was no significant difference between high and low dosage
groups. Statistical analysis used: 1-way ANOVA followed by a post hoc. * represents
P < 0.05, N = 6.
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Observation of Age Related Effects on Expression of GDNF Protein in the
Brains of Rats
Comparative observations were made of the control rats from the 7-days
A1254 exposed (short term) 28-days A1254 exposed (intermediate), and 84-days
A1254 exposed (long term) animals. The observations revealed a natural significant
reduction in GDNF as the animals aged. These data are shown in (Figure 2.7).
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Figure 2.7. Relationship of Brain GDNF Protein Content with Age.
GDNF protein content in brains of control rats is plotted against age, for three
specific age groups. Results show that there is a reduction of brain GDNF
protein content with increase age. Four 8 week, six 13 week and four 19 week
old rats were tested for GDNF protein content of their brains. The protein data
was obtained by ELISA from one brain hemisphere of each animal.
Statistics: 1- way ANOVA followed by post-hoc testing.

A 2-way ANOVA with age and treatment as variables, followed by StudentNewman-Keuls post hoc was also performed for all animals. Increase in age was
negatively correlated with GDNF protein levels for all groups: P < 0.01, N = 42.
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Results from Studies on Effects of Aroclor 1254 on Spatial Learning and
Memory
Prior to the removal of whole brains from 18 Fisher 344 rats, they were tested
for the effects of dietary exposure to Aroclor 1254 on spatial learning and memory.
The results indicated that animals treated with 5Oppm A1254 exhibited significantly
more errors during the acquisition phase than those treated with lOppm or control
animals. In addition, the control group o f rats tended to exhibit greater evidence of
learning and better reference memory. The deduction was made based on observation
(During the Delay Win-Shift tests) of subjects making less mean number of errors or
repeated entries from one delay to another (Paris-Larson, 2004). The results suggest
that dietary exposure o f rats to A 1254, caused impairments in their performances on
the RAM tests.

Discussion
In this study there has been considerable evidence provided suggesting that
PCBs affected the overall level of the NF proteins, in the brains o f exposed rats. The
A1254-induced NF protein reductions were seen following short-term exposure (7
days), intermediate exposure (28 days), as well as a long-term exposure (84 days). In
addition, it appeared that A1254-induced NF protein reduction in the brains of the
animals that underwent behavioral studies may be correlated to impaired
performances in the RAM exercises. An important observation is that the A 1254
effect on the NF protein levels, in the brains of the rats that underwent the RAM test,
was relatively long-lived. Considering that even after 6 weeks of recovery (taken off
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the A1254 diet), there were still observable reductions in NGF, BDNF and GDNF
protein levels in their brains. This may be due to PCB’s ability to remain in body
tissue, especially adipose, for longs periods of time even extending into years. The
brain is among the organs found to have the highest PCB concentrations in exposed
individuals (Argonne National Laboratory 2005).
It was observed that the level of GDNF protein in the brains of rats we tested
naturally declined with age (figure 2.7). The difference between the protein content
measured from the adolescent (2 months old) rats and that from the mature (5 months
old) rats represented an 80% reduction. Despite this age related decline in GDNF
protein level in rat brains, there was significant reduction in rats exposed to A 1254
relative to the controls at all ages for which tests were carried out in this study.
Based on these results it appears that A 1254 significantly exaggerated the natural
decline in GDNF protein in the brains of exposed rats, by the time of maturity. We
suggest that such induced reduction may have negative consequences on brain
processes that depend on natural levels of GDNF protein in the brain.
In comparing results after 7 days of exposure to a prolonged duration of 84
days, we observed a stronger effect in animals we tested after the shorter exposure
period. It seems that although the effect on NF levels in some cases was still
significant after 84 days of exposure, that there had been some ablation with time,
especially for the high dose group. This we determined by comparing the percent
difference in NF protein levels (NGF and GDNF) from control of 7-days A1254
exposed rats with the percent difference obtained from the 84-days A1254 exposed
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animals and their controls (figure 2.3). Moreover, the significant difference in NGF
protein level seen ivith the shorter exposure time disappeared by the end of 84 days of
A 1254 exposure. When animals are exposed to non-lethal dosages of a toxin, the
reaction to that toxin on initial introduction may be different than that after prolonged
exposure (Klein 1996). Factors such as accumulative effects or induction of intrinsic
adaptive mechanisms may be contributors to the changes in response observed. It was
Dr. H.F. Smyth, Jr., a toxicologist, who first coined the term "sufficient challenge"
based on his observations o f toxin-exposed laboratory animals. He discovered that
animals to which he fed toxins actually got healthier at a certain point before showing
signs of toxicity (Ottoboni 1991).
Ultimately we wanted to determine whether animals that showed altered NFs
in their brains as a consequence of PCB exposure, would also exhibit signs of
compromised cognition. We compared the results obtained from the behavioral test
(RAM) involving the 28-days A1254 exposed animals with the NF results obtained
from brains taken from these animals. Interestingly, it was found that A 1254 exposed
animals shown to have reduced levels of NFs, also exhibited poorer performances on
the spatial learning and memory exercises, compared to controls. Low performance
on the RAM test by A1254 exposed rats is supported by a study that reported male
rats being exposed to A1254 during lactation, exhibited impaired RAM performance
at adulthood (Roegge et al. 2000).
The NF analysis of the rats used in the RAM test showed no significant
difference in NF protein levels between lower and higher A1254 dosage groups; and
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in the case of BDNF, the 5Oppm exposed group even had significantly higher levels
than the group exposed to lOppm. Since these animals had 6 weeks of recovery from
A1254 exposure before their brains were analyzed for NF protein content, it may
suggest that six weeks o f recovery allowed for improvement in NF protein levels in
the animals that received the higher A 1254 dose.
The behavioral investigator reported that the 5Oppm A1254 group of animals
made significantly more mistakes than the lOppm exposed group (Paris-Larson,
2004). This does not necessarily contradict the biological outcome seen for example,
in the BDNF results shown in figure 2.5. It may indicate that there is no correlation
between NF protein and behavior problems for BDNF or it may just be recovery at the
NF protein level for BDNF. If in fact, there is a recovery effect for NF expression, it
is reasonable to deduce that the greater the insult the greater the recovery, temporary
though it may be. If we are assuming however, that extrinsic induced alterations of
NFs in turn affect their influences on neuronal structural changes involved in
cognition, then a temporary recovery at the level of NF expression, may not parallel a
concomitant recovery at the level of cognition.
This study is intended to stimulate thinking along the presented line of
arguments. It is difficult to elucidate in vivo; the sequence of molecular events
involving introduction of PCBs at the level of brain tissue and the subsequent
involvement of NFs and neuronal functions leading to compromised cognitive
abilities. The work done here is just skimming the surface of potential discoveries.
But all successful endings must have a beginning and this study is an important
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beginning. From the biological and behavioral observations of these studies, we set
out a speculative model represented by the following cartoon, for an indirect effect of
PCBs on learning and memory.

Disrupt
homeostasis

Compromised
Cognition

Figure 2.8. Illustrative Model of a Possible Sequence Leading to an Indirect
Effect of PCBs on Learning and Memory
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OVERVIEW OF CHAPTER II AND LINK TO CHAPTER III

In the previous chapter, the investigations and results of effects of PCBs
(A1254) on NF protein expression in the brains of exposed rats were presented. It
was found that A 1254 caused reduction in NF protein levels in brains of exposed rats.
The effects of the higher A1254 dose (50ppm) on NGF and GDNF tended to be more
intense with the short term exposure (7 days) than after 84 days of exposure. Rats
exposed to A1254 for 28 days and then subjected to the RAM test following 5 weeks
of recovery during which they were trained, showed poorer performance than
controls. Analysis of brains from animals in the RAM study showed significant
reduction in brain NGF, BDNF and GDNF protein.
The aim of the studies in this chapter was to compare the in-vivo response (on
the level of brain NF expression), to lead exposure with that o f A1254 exposure.
Here, the effects of lead (Pb) a neurotoxin known to affect learning and memory, was
examined.
The association of Pb exposure with decline in cognitive fimction especially in
children but also in adults has been widely studied and documented. One study
reported that progressive and ongoing decline in cognitive function, particularly
functions such as learning and memory; is associated with adult lead exposure long
after exposure ceases (Schwartz et al. 2000). Because Pb has similar effects on
cognition as PCBs, and because we are suggesting a role for NFs in activities of
PCBs, we were curious as to whether NFs were targets of Pb as well.
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CHAPTER III
THE EFFECTS OF LEAD (PB) ON NEUTROPHIC FACTOR EXPRESSION
IN THE BRAINS OF EXPOSED RATS— HOIFDOES IT COMPARE TO THAT
OFPCBs?

Introduction
Lead
Lead is a common element of the geosphere, but its ubiquitous presence in the
environment in bioavailable forms is largely due to human activities (Rice 1995).
Between 1969 and 1971 an ore smelter in El Paso, Texas had discharged 1,116 tons
of lead into the atmosphere. Studies conducted close to these smelters, reported that
lead emitted and deposited in soil and house-hold dust, appear to be the major source
of lead absorbed by humans (Rosenblum et al. 1973). Lead based paints and gasoline
had been “human responsible sources” of Pb since the 1970s. Within recent times
however decreases in the use of leaded gasoline and lead-based paints in the USA
have resulted in reductions of lead exposure and blood lead levels (BLLs) (ATSDR
1999). BLLs are used as an index of exposure and hence health risks.
Recent studies have lead to a greater awareness o f health hazards posed by
lead toxicity at much lower BLLs than first expected. In 1971 “undue lead
absorption” referred only to BLLs equal to or greater than, 40 pg/dL. But several
subsequent studies reported how BLLs much lower than 40 pg/dL adversely impacted
the health of children without causing overt symptoms (Matte and Falk 1997).
Although lead poisoning can be the result of one high dose, the more common
occurrence is due to prolonged exposure to small amounts. There is discrepancy
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among researchers and doctors as to what BLL is safe in humans (Hess 2004). One
study showed that declines in IQ can be seen in children with blood Pb concentrations
below 10 gg/dL (Canfield et al. 2003). The following table: 3.1 from (Hess, 2004)
shows results of recent studies linking potential health problems, to measured BLLs in
exposed individuals.

Blood lead level

Possible effects

Below 10 pg/dL

May result in small declines in intelligence

10 pg/dL or
above

Can impair the learning, growth, and development of
young children

15-20 pg/dL

Can harm the body's ability to transport oxygen
May reduce the amount of vitamin D in the body
(necessary for the proper formation of bones and teeth)

Up to 25 pg/dL

May affect intelligence (lower IQ)
May slow reaction time

Up to 70 pg/dL
Above 70 pg/dL

May cause any of the conditions listed above
May cause:
Further damage to the brain and nervous system
Anemia, which is a decrease in the amount of oxygencarrying substance in red blood cells
Stomach pains
Kidney damage
Lead encephalopathy, in which extremely high levels of
lead cause the brain to swell, increasing pressure within
the skull

Table 3.1. Health Risks Associated with Blood Lead Levels (BLLs). Obtained
from (Hess, 2004)
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Although the relationship between lead exposure and cognitive development
has been a lively controversy among certain researchers (Burger and Gochfeld 2004),
many studies agree that even at low doses, lead exposure can produce serious adverse
effects on the central nervous system o f children and that these effects can last for
years.
In chapter II we presented our findings on effects of PCBs on levels of
different NF in the brains o f exposed rats. Results of these studies indicated that
PCBs caused reduction in NGF, BDNF and GDNF in the brains of these rats. We
speculated that such alterations of NF expression may cause altered neural processes
and functions leading to compromised cognitive ability.
Since lead has also been shown to be neurotoxic, and to be associated with
cognitive impairment in exposed children, we were curious about the possibility that
NFs may be general targets for neurotoxins that affect cognition. The focus of this
study therefore was to determine whether NF protein expression is altered in the
brains of rats exposed to lead in their diet.

Methods and Materials
Lead Exposure
Six weeks post-weaning male Fischer 344 rats were exposed to 0 ppm, 50
ppm or 500 ppm o f Pb^^' in the form of lead acetate, in their drinking water for 30 or
90 days. The control animals were given distilled drinking water. Prior to treatment,
all rat diet and drinking water were analyzed by ICP-MS for lead content. Rats were
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housed at the Western Michigan University Animal Facility. The animals were
treated according to the principles outlined in the NIH Guide for the Care and Use of
Laboratory Animals. After each exposure period, rats were euthanized with CO2;
eight rats per treatment from the 30 days exposed group and 5 per treatment form the
90 days exposed group. Following euthanization, the animals were decapitated using
a rat guillotine and their brains were removed within 3-4 minutes. Upon excision, the
brains were hemisected and immediately dropped into 2-butyl butane cooled on dry
ice. Excess fluid was decanted and the brains were stored at -80 degrees until
processing for NF content.

Brain Processing
Each hemisphere to be used for NF quantitative analysis was weighed and
then crushed in a polythene envelope by hammering on an aluminum plate cooled
with dry ice. The resultant powder was put into a glass homogenizer and
homogenized in 4-5 ml sample processing buffer (See appendix for buffer recipe) on
wet ice to minimize protein degradation. Homogenate was transferred to centrifuge
tubes and spun in an ultra centrifuge at 2400 rpm for 40 min at 4 ”C. The supernatant
was collected and stored at -20 °C.

Enzyme Linked Immunosorbent Assay (ELISA)
We followed the procedure outlined in the method section of chapter II for the
ELISA o f NGF and GDNF. Ninty-six well plates were used and each sample was
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pipette in quadruplicate into columns of wells. A serial dilution ranging from 0 1000 pm/ml o f NGF and GNDF proteins (obtained from and R&D) was prepared as a
standard curve. Following color development, plates were read at 450 nm in a plate
reader. Average values for samples were calculated and NF concentrations were
extrapolated from the log standard curve.

Determination of Lead Exposure—Blood Lead Level (BLL)
Rats were exposed to lead acetate Oppm 5Oppm or 500ppm in their drinking
water. The BLL o f each exposed rat was determined by Inductively Coupled Plasma
Mass Spectrometry (ICP-MS).

Results
30 Days Lead Exposure Results
The NGF and GDNF protein contents of the brains of the lead treated rats
were determined by ELISA. A 1-way ANOVA was performed for comparison
between groups. Results showed no significant difference between groups for NGF
or GDNF protein. The data is given in the following table 3.2:
Treatment

NF in pg/mg brain

Mean

N

SE of mean

Control (Oppm Pb)
Low dose (50ppm Pb)
High dose (500 ppm Pb)

NGF
NGF
NGF

4.58
5.53
4.89

8
7
8

0.68
0.71
0.35

Control (Oppm Pb)
Low dose (50ppm Pb)
High dose (500 ppm Pb)

GDNF
GDNF
GDNF

4.52
4.77
3J2

8
7
8

0.93
0.72
0A6

Table 3.2. NF Protein Content in Brains of Rats Exposed to Lead for 30 Days
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The BLLs of each of the 15 lead exposed animals were plotted against
corresponding NF levels, obtained by ELISA. A linear regression was performed in
order to determine if BLL was a reliable predictor of brain NF level. Results showed
no significant relationship between BLLs and brain NGF expression (figure 3.1).
There was however a significant correlation between BLLs and brain GDNF
expression, with higher BLLs being associated with lower GDNF levels (figure 3.2).
Control rats, which had insignificant BLLs, showed no relationship between BLLs
and brain GDNF expression. The inclusion of the data Ifom control animals in the
linear regression did not change the outcome. These findings suggest that lead
exposure may affect GDNF expression in the brains of exposed animals.

90 Days Lead Exposure Results
Data from the results o f this experiment was analyzed as previously mentioned
for the 30 days Pb treatment experiment. Results showed no significant difference
between groups for NGF or GDNF protein. The data is given in the following table:
Treatment

NF in pg/mg brain

Mean

N

SE of mean

Control (Oppm Pb)
Low dose (5Oppm Pb)
High dose (500 ppm Pb)

NGF
NGF
NGF

323
2.49
2.91

5
5
5

0.22
0.42
0.27

Control (Oppm Pb)
Low dose (5Oppm Pb)
High dose (500 ppm Pb)

GDNF
GDNF
GDNF

4.20
3.49
3.57

5
5
5

1.63
0.98
0.64

Table 3.3. NT Protein Content in Brains of Rats Exposed to Lead for 90 Days
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Regression analysis was also performed in order to determine if BLL was a reliable
predictor of brain NF level. Results showed no significant relationship between BLLs
and NGF or GDNF protein levels in the brains of the animals treated with lead for 90
days. (Data not shown)
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Figure 3.1. The Relationship between Blood Lead Levels and NGF Protein
Expression in Brains of Rats Exposed to Lead in Their Drinking Water for 30
Days. The figure shows the BLLs from 15 exposed rats. Seven rats were exposed to
SOppm and 8 were exposed to SOOppm lead, respectively, in the form of lead acetate
in drinking water. There was no significant relationship between BBLs and brain
NGF expression. Statistical method: Linear regression, N = 15.
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Figure 3.2. The Relationship between Blood Lead Levels and GDNF Protein
Expression in Brains of Rats Exposed to Lead in Their Drinking Water for 30
Days. The figure shows the BLLs from 15 exposed rats: Seven rats exposed to
50ppm and 8 were exposed to 500ppm of lead in the form of lead acetate in drinking
water. The data show a significant negative relationship between BLLs and brain
GDNF expression. Statistical method: Linear regression followed by Pearson Product
Moment Correlation: correlation coefficient = - 0.638, P = 0.0105, N = 15.
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Discussion
The objective o f this study was to investigate the effect of Pb, a known
neurotoxin, on brain NF levels. We chose Pb because of the similarity in its effect on
neuronal functions with those o f PCBs,’ especially in children.
There was no difference in NF protein content in the brains of rats treated with
5Oppm or SOOppm Pb compared to that in control rats. We believe this was due to the
high variability in actual lead consumption, since the animals drank the lead treated
water ad libitum. Comparing BLLs to brain GDNF levels on an individual basis
however, showed that there was a significant negative relationship between BLLs and
brain GDNF levels in exposed animals. The results for NGF under identical
experimental procedure showed no correlation between BLLs and NGF protein
content. We do not know any in-vivo mechanism by which either of these
neurotoxins, PCBs or Pb, exert their effects on NF expression, yet the effect is
similar. Exposure to lead seems to be associated with significant alteration in the
expression of the neurotrophic factor GDNF. Interestingly, a recent study found that
lead exposed rats in an impoverished environment had significantly decreased NF
gene expression in the hippocampus (Schneider et al., 2001 in: (Lidsky and Schneider
2003). We found decreased GNDF protein levels in brains of lead exposed rats.
We have been able to demonstrate that two different neurotoxins (PCBs and
lead) which have been associated with adverse effects in neuronal functions also
caused reductions in brain NFs. The importance of NFs to the nervous system and
learning and memory, has been previously discussed in chapter 3. The relationship
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between compromised cognition and significant interference of the homeostasis of
NFs has been clearly established and documented by several studies. The
mechanisms by which PCBs and lead affect NFs may be quite different, the fact that
they do however, suggests that neurotoxins capable of affecting learning and memory
may do so, in part, by interfering with the homeostasis of NFs thereby altering the
influence these NFs have on processes like, synaptogenesis and neuroplasticity.
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OVERVIEW OF CHAPTER III AND LINK TO CHAPTER IV
The previous studies investigated the effects of PCBs and lead (Two known
neurotoxins) on the expression of NFs in brains of exposed animals. It was shown
that PCBs altered the expression of NGF, BDNF and GDNF in the brains of rats that
were exposed to A1254 in their diets. It was also shown that BLLs correlated with
reduced GDNF protein levels in the brains of rats exposed to lead acetate in their
drinking water.
Complementary in-vitro studies are very useful because they allow for greater
manipulation and ease of determination o f the treatment environment. The following
manuscript (chapter IV), presents the in-vitro aspects of this dissertation. Presented
are morphological and physiological responses to A1254 exposure of glial cells in
culture.
The model of study was a glioma cell line called C6. These were exposed to
lOppm A1254 in culture for specific exposure periods. Medium from these cultures
were assayed to determine levels of secreted NF protein. Total mRNA was extracted
from control and A1254 exposed cells and analyzed by RT-PCR to determine effects
on GDNF gene regulation. A possible signal pathway by which A1254 exerts its
influence was also determined.
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CHAPTER IV
EFFECTS OF POLYCHLORINATED BIPHENYLS (PCBs) ON EXPRESSION
OF NEUROTROPHIC FACTORS IN
C6 GLIAL CELLS IN CULTURE

Introduction
PCBs are persistent environmental toxic pollutants which accumulate in food
chains in contaminated areas (ATSDR 1999, ATSDR 2000, Li and Hansen 1997).
Commercial mixtures of PCBs called Aroclors, which are made up of several
individual congeners, were manufactured in the United States for almost 50 years.
They were produced for use as nonflammable dielectrics in electronic parts,
lubricants, plasticizers in caulking compounds, paints, adhesives and sealants,
vehicles for pesticide application, and pigment suspension agents in carbonless copy
paper. (Korrick and Altshul 1998, McKinney and Walter 1994). One of these PCB
mixtures, called Aroclor 1254 (A1254) was the most commonly sold and is the one
most commonly found at contaminated sites. (Tilson and Kodavanti 1997)
PCBs are exceedingly toxic and have been shown to cause health problems in
humans even at low levels. Human exposure to PCB can be through inhalation
(respiration), digestion, or through the skin (dermal absorption) (EPA). They are
lipophilic and are present in the fat of all human populations. A major concern has
been that of prenatal exposure (trans-placenta) and postnatal exposure (from breast
feeding) (Korrick et al., 1998) Epidemiological studies in humans have demonstrated
a variety of nervous system deficits associated with PCB exposure, including
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alterations in function of the peripheral nervous system (Chia and Chu 1984) and
central nervous system (Jacobson and Jacobson 1997, Jacobson JL. et al. 1990).
Impairments in learning and memory have been documented both in young
(Grandjean et al. 2001) and older humans (Schantz et al. 2001) following
environmental exposure to PCBs (Widholm et al. 2001). Developmental exposure to
PCBs has been associated with cognitive deficits in children and experiments with
rodents have revealed impairments in learning tasks that involve the hippocampus
(Gilbert et al. 2000).
Although PCB exposure has been shown to alter a variety of intracellular
signaling processes, including calcium signaling, protein kinase C signaling and
neurotransmitter synthesis (Tilson and Kodavanti 1998), very little is known
concerning the mechanism by which PCBs alter neural functions. The risk to the
developing nervous system posed by PCBs is difficult to asses due to a general lack of
information on mechanisms by which PCBs induce neurotoxicity (Howard et al.

2003^
The main objective of this study was to determine the effects o f PCBs on the
expression of an important class of proteins called neurotrophic factors (NFs) that are
essential to the development and maintenance o f the nervous system. These we
studied in glial cells, a nervous system cell type that is known to synthesize them.
NFs are important for the growth of neurons and for regulation of phenotypic
expression during development. Several critical aspects of the ontogeny of neurons;
determination of neuronal population, neurite branching and synaptogenesis, and
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synaptic plasticity in adults are regulated by NF (McKay et al. 1999, Sariola and
Saarma 2003). Most neurons require a sustained supply o f these trophic factors
throughout their lifetime for normal maintenance and for recovery from nervous
system injury in the adult organism. (Catapano et al. 2001, Mattson et al. 2002)
PCBs have been shown to alter neurotrophic factor in whole animals. One
study showed that exposure oîXenopm laevis tadpoles to A 1254 at a concentration
level as low as 300-400 ppb, caused significant decrease in NGF gene expression.
Subsequent observable health effects were evident consequences (Jelaso et al. 2003).
We investigated the possible NF altering effeet of A 1254 in culture glial cells.
Glial cells are a possible source of NF in the brain. There are 10 - 50 times as many
glial cells within the brain as neurons. They make up 90% of brain cells. Until
recently, glial cells have been thought to be important only as integral support cells of
the nervous system, but this concept has changed since it has recently been shown that
glial cells play a role in synapse formation. Astrocytes in particular are believed to
actually ‘instruct’ neurons to make synapses (Miller 2003). It has been reported that
although neurons can form synapses without glia, they may require them to form high
numbers of efficient synapses, suggesting glia as a source for synaptogenesispromoting signals (Mauch et al. 2001, Pfneger 2002). Given these attributes and the
fact that glial cells produce NFs, they are important models for preliminary studies
involving toxic exposure. Results from this study may offer valuable incites towards
unraveling a mechanism by which PCBs interfere with neural processes and
functions.
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Methods and Materials
Tissue Culture
For routine cell culturing we used a medium consisted of: Delbeco’s
Modified Bagels's Medium (DMEM) {Sigma, St. Louis MO) + 10% fetal bovine
serum (PBS) {Invitrogen) + antibiotic-antimycotic (Sigma St. Louis MO), hitherto
referred to as medium For some experiments in which cultures had to be maintained
for long periods in the same medium, the cells were grown in medium supplemented
with extra glucose (3.5g/L). All medium or buffer solutions were initialized to pH
7.4.
Initial cultures of C6 glial cells (a rat glial cell-line), were established in sterile
100 nun dishes to provide cells for designed experiments. Cells were seeded at
pproximately 2x 10^ cells/cm^ and incubated in a humidified chamber at a constant
5% CO2 and 37 °C. When initial cultures proliferated to 60 - 70% confluence the
cells were lifted with 10% trypsin/EDTA (Invitrogen) (in Calcium and Magnesiumfree buffered Tyrodes) and then re-suspended in medium. For experiments, samples
of the cell suspension were then used to seed 60rmn sterile culture dishes at a cell
density of approximately: 2x10^ cells/cm^, and then incubated to proliferate to
100% confluence.
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Dose Response Treatment
C6 cells were cultured in medium containing A1254 (Ippm, lOppm, 25ppm
and SOppm) + DMSO (0.01%, 0.1%, 0.25% and 0.5%) respectively, DMSO at the
four latter listed concentrations, or in just medium. The eells were monitored visually
with an inverted microscope immediately after treatment and then at 10 min, 30 min,
60 min and 24 hrs or longer post-treatment.

Live/Dead Cells Determination
PCB-treated and control C6 glial cells were incubated in 60mm culture dishes
for 72 hours or 5 days. After two washes with warm phosphate buffered saline (PBS),
plates were ineubated for 30 minutes with 2 mM Calcein A M (a dye taken up only by
live viable cells) and for 10 - 15 minutes with 4 pM ethidium homodimer-l(EthD-l),
a dye that enters only dead cells. Calcium AM is virtually non-fluorescence until it is
cleaved by intracellular esterases in living eells to produce an intense uniform green
fluorescence. EthD-1 is excluded by living cells but enters damaged membranes of
dead eells and upon binding to DNA produces an intense red fluorescence color
{Molecular Probes'). Examination o f the stained cells was done with a Nikon
microscope utilizing fluorescent filters selected for excitation/emission at
wavelengths 495/515 and 495/635 nm. Total live and dead cells were counted from
eaeh o f 8 random visual fields from 2-3 plates per treatment, and averaged to
determine the live-dead ratio.
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Culture Treatment and Sampling
For all subsequent experiments, when initial C6 cell cultures attain 100%
confluence, all medium was removed and plates were replenished with medium
containing lOppm A1254 + 0.1% DMSO, 0.1% DMSO or normal medium. Each 60
mm plate was loaded with 2 ml of medium. Three plates per treatment were cultured
for each of the time points: 6,24, 48 and 72 hours or 5 days. This configuration was
chosen to allow each plate to be sampled only once for consistency o f treatment
concentration at all times. Medium samples were taken for all but the 5 day time
point and stored at -20°C. The 5-day old cultures were collected for PGR analysis.
Each experiment was repeated a minimum o f 5 times. In a subset of experiments,
cells from some time points were harvested to facilitate NF normalization per cell.

Culture and Treatment for Effect-on- Proliferation
C6 cells were cultured in 60mm culture dishes and treated as described
previously described, one dish per treatment. All medium was withdrawn and cells
were counted at 6 hours and 72 hours, those being the earliest and latest time-points
of treated culture medium sampling. Cells were lifted with trypsin as previously
described, resuspended and counted using a hemocytometer.
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Culture, Treatment and Sampling for Cell Lysate NGF and GDNF
Determination
C6 glial cells were grown in medium supplemented with 3.5g/L glucose and
treated with lOppm A1254 + 0.1% DMSO or 0.1% DMSO for 6 hrs and 72 hrs. Cells
were trypsinized, washed in C a^ M g ^ free Tyrodes and centrifuged at approximately
1200 rpm. The supernatant was removed and pellets were weighed. Cells were then
re-suspended in Cell Lysing Buffer consisting of: 10% (Stock lOX prod. # 9803, from
Cell Signaling Technology) + lOmM Benzethonium chloride, 200mM benzamidine,
and 164 pL/100ml aprotinin (Sigma). Cells were allowed to vibrate in lyses buffer for
an hour and then were centrifuged at 24,000 rpm for 45 min. The supernatant was
analyzed for NF by ELISA. NF concentrations were standardized to corresponding
cell (pellets) weights.

Cell Fractionation for Intracellular PCB Binding Assay
A1254 treated C6 glial cells were washed with C a^ M g^ free Tyrodes, and
their outer membranes were disrupted by vibration in mild lysate buffer as previously
mentioned. Separation of sub-cellular components was done by differential
centrifugation as follows: The resulting mixture of sub-cellular organelles was
placed in a centrifuge and spun at lOOOg for 10 min. The resulting pellet would
normally consist of intact cells, cell membrane and nuclei. The supernatant was then
decanted and re-spun at 10,000g for 20 minutes. Intermediate subcellular particles
such as mitochondria and lysosomes would normally be in the sediment (pellet) at this
stage. The supernatant was carefully decanted into a storage tube. This supernatant

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

70

would at this stage contain the tiniest and lightest particles such as, endoplasmic
reticulum fragments, ribosomes and microsomes. The intracellular PCB analysis was
performed using a modification of that used by Means (1998).

Enzvme-Iinked Immunosorbant Assay (ELISA)
Neurotrophic factor concentrations in all sampled mediums and supernatants
were determined by ELISA. All NGF and GDNF proteins and antibodies were
obtained from R&D systems.
Anti-NGF or anti-GDNF mono-clonal antibodies diluted in PBS, were added
to 96 well ELISA plates, which were then sealed and allowed to incubate at room
temperature overnight, for antibody adherence. Plates were then washed with PBS
and blocked with 1% BSA for 1 hour. Blocker was washed from plates and NF
protein standards and experimental samples were added and incubated for 2 hours
while being gently swirled. The plates were washed (one 1 min. and two 5 min.
washes) and a polyclonal antibody (conjugated to biotin), which was diluted in Tris
Buffered Saline (TBS) + 0.1% Bovine Serum Albumin (BSA) and 0.3% Tween-20,
was added. Plates were allowed to incubate for two hours. After washing, the plates
were incubated for 20 min. with streptavidin HRP {Pierce). After washing off
unbound HRP, the color reagent (tetramethyl benzidine in phosphate citrate buffer)
was added. When color developed (generally, color indicator developed fully by 10
minutes of incubation), the reaction was stopped with 0.1 M phosphoric acid. The
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plates were then scanned at 450 nm wavelength using a microplate scanning
spectrophotometer {Bio-Tek Instruments).
For each assay, standards and samples were assayed in quadruplicate. For
experiments that assayed samples from different exposure times, the protein values
from three plates per treatment for each time point were averaged. NF protein
concentrations were determined by interpolation from a log standard protein curve
plotted from serial dilutions ranging from 0 - lOOOpg/ml diluent (example: culture
medium or lysing buffer solution).

Messenger RNA Isolation for RT-PCR
Messenger RNA (mRNA) was isolated from cultured C6 cells (n = 5) using a
Poly (A) Pure mRNA isolation kit following the manufacturer’s instructions
(Ambion, Austin, TX.). Cells from the different treatment groups were collected,
centrifuged and washed in Rnase-free PBS. For each culture treated for real-time RTPCR analysis, 50 ng of yeast mRNA (Clontech, Palo Alto, CA) was added to the
homogenate (Jelaso et al., 2003) to serve as an exogenous control/standard.
Messenger RNA concentration of each treatment group was determined by measuring
the absorbance at A260 using a GeneQuant Pro spectrophotometer (Amersham
Pharmacia Biotech, Piscataway, NY) (Jelaso et al., 2003)
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Real-Time RT - PCR
We determined GDNF gene expression in C6 cells utilizing the Taqman PCR
method, a recently developed technique for the rapid and accurate quantification of
gene-specific mRNA. This method takes advantage of the 5’ nuclease activity of Taq
polymersase to cleave a dual labeled fluorescent probe. There is a linked fluorescent
reporter dye to the 5’ end of the probe while a fluorescent quencher dye is attached to
the 3’ end (Jelaso et al., 2003). The gene sequence for Rat GDNF was obtained from
GenBank. The probe and primers were purchased fi’om Applied Biosystems and are
as follows: Forward Primer (GACTTGGGTTTGGGCTACGAA), Reverse Primer
(TCTCGGCCGCTTCACAG), and TaqMan TAMRA Probe
(CAAGGAGGAACTGATCTTTCGATATTGTAGCGG).
Each RT-PCR reaction was performed in a 25 pi final volume containing
1.25 U/pl o f MultiScribe reverse transcriptase, forward and reverse primer, 200nM
Taqman probe, 2X Master Mix without UNG (uracil A-glycoslyase) and an equivalent
concentration of mRNA template from each treatment group. All RT-PCR reagents
were purchased fi*om Applied Biosystems. All RT-PCR runs contained control
reactions lacking template and reverse transcriptase. Four or five point standard
curves were generated using serial dilutions of mRNA from untreated cells. All
reactions were run in duplicate in 96-well plates. An Applied Biosystems Prism 7700
Sequence Detection System was used for amplification and fluorescence detection.
Thermal cycling parameters—48°C, 30 min, 10 min at 95°C, and then 40 cycles of
95°C, for 15 sec, 60°C for 1 min. (Jelaso et al., 2003).
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Treatment with PKC Inhibitor
To determine the role of Protein kinase C (PKC) in effects induced by A1254,
a PKC inhibitor, 2-[l-(3-Dimethylaminopropyl) indoI-3-yl]-3-(indol-3-yl) maleimide
(bisindolylmaleimide or bis) (TOCRIS) was applied. PCB treated and control cells
received 0.132 pM bis, which targets the a , (51 and s PKC isoforms, or 5.8 pM bis
that also targets the Ç isoform but will also inhibit other kinases such as PKG and
PKA. Con-currently, PCB treated and control cells were cultured free of the PKC
inhibitor to serve as bis controls. Exposure time was 24 hours prior to medium
sampling.

Results
Observable Effects of Aroclor 1254 on C6 Cells
Treatment with DMSO (0.01% - 0.5%) had no observable effect on cells
monitored up to 24 hours. Cells exposed to 10 ppm A1254 + 0.1% DMSO or 20 ppm
A1254 + 0.2% DMSO for 24 hours also had normal appearance and continued to
proliferate. Treatment with 50 ppm A1254 + 0.5% DMSO however, had pronounced
observable effects. Within 20 minutes of treatment, clear vacuoles were observed
surrounding nuclei of cells. After 60 minutes there was an increase in the incidence
of both clear and dark vacuoles as well as retraction of glial processes. Following 24
hours of treatment, all PCB exposed cells contained numerous clear vacuoles with
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cells displaying membrane blebbing. By 72 hours the majority of cells treated with 50
ppm A1254 + 0.5% DMSO had lifted off the substrate.
Results from live/dead analysis of cells using Calcien (for live cell detection)
and EthD-1 (for dead) showed, that cells exposed for up to 5 days to a lower dose of
A1254, 10 ppm, exhibited no difference in cell mortality compared to controls. More
than 95% of cells for all treatments were alive and viable (Table 4.1). The following
photos show examples of visual fields from which the live/dead ratio was obtained
(Figure 4.1).

Same visual field

ive

->

(DMSO treated)

Same visual field

->

Figure 4.1. Comparison of Effect of lOppm A1254 and 0.1% DMSO (Vehicle) on
Mortality of Glial Cells in Culture. Visual fields show live (green) and dead (red)
C6 cells.

Having shown that neither A1254 (lOppm) + 0.1% DMSO nor 0.1% DMSO
caused any difference in cell death compared to untreated controls, we proceeded to
determine whether A1254 or DMSO at the same previously given dosage had an
effect on cell proliferation. Cells were seeded at a constant density of 2 x 10^ /cm^
and allowed to grow to 100% confluence. Control and treated cells were incubated for
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6 hrs or 3 days to test both acute and chronic effects. Cells were counted and the
mean number of cells per plate per treatment were compared (Table 4.2). It was
determined that neither PCB nor DMSO had a significant effect on cell population
when compared to untreated control cells.

Results of Intracellular PCB Binding Analysis
In order to roughly determine the binding activity of A1254 once it had
entered the cells, C6 glial cells were subjected to membrane disruption followed by
separation o f sub-cellular fractions by differential centrifugation. Intracellular PCB
analysis was performed according to Means (1998). It was found that while there
was insignificant DMSO associated with cell membranes and inclusions (indicating
that most was dissolved in the cytosol), significant A 1254 was found bound to cell
fractions. Most o f the A1254 was found in association with small cell-inclusions,
which will include ribosomes, ER, microsomes etc. The second largest association
was with larger cell inclusions, which will include nuclei and mitochondria. There
was also some cell membrane-bound A1254 (figure 4.2). These results confirm that
PCBs dissolved in DMSO, efficiently cross the cell membrane; and can bind to
receptors on the nucleus and other organelles, with little or none remaining in the
cytosol.

Effect of Aroclor 1254 on GDNF and NGF in C6 Ceils
To test whether PCBs affect NF secretion by cultured glial cells, confluent
cultures were exposed to 0.1% DMSO or A1254 (10 ppm) + 0.1% DMSO for 24
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hours. Following medium sampling, the cells were counted and NF concentration
was calculated per cell. A1254 induced a significant increase in the secretion of both
NGF and GDNF by C6 cells in culture; One way ANOVA followed by Dunnettes
Post Hoc, P < 0.01 (Figure 4.3).

Effect of Aroclor 1254 on GDNF in C6 Ceils for Up to 72 Hours of Exposure
To determine the time course of effect on GDNF secretion, cells were treated
and samples of conditioned medium were taken at various times following exposure.
Cells were exposed to the treatments in medium supplemented with 3.5g/L glucose.
GDNF content of conditioned cell culture medium was determined by ELISA.
Medium sampled at 6hr from control cultures contained; 7.4 ± 0.1 pg GDNF m l'\ fri
control cultures the concentration of GDNF decreased by 24 hr and then increased at
48 and 72 hours (Figure 4.4). Neither A1254 nor DMSO had an effect on the pattern
of GDNF secretion by control cells. Comparison o f GDNF quantities at each time
point however, indicated that the A 1254 treated cultures had significantly higher
concentrations for all time points (One-way ANOVA followed by Dunnette Post
HOC, P<0.05) (Figure 4.4).

Aroclor 1254 s Effect on Intracellular GDNF and NGF in C6 Glial Cells
To determine whether PCBs exert effects on intracellular stores of NGF and
GDNF, cells were exposed to A 1254 and content of NGF and GDNF in cell lysate
was measured. The results showed that there was no difference in intracellular NGF
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or GDNF levels in C6 glial cells treated with A1254, compared to untreated controls
(Table 4.3).

R T -P C R Results
To determine whether exposure to PCBs affected GDNF gene expression,
GDNF mRNA from treated and control C6 cells was measured utilizing real time RTPCR. Total mRNA was extracted from cells exposed for 5 days to Oppm A 1254,10
ppm A1254 + 0.1% DMSO or 0.1% DMSO, in medium supplemented with 3.5g/L
glucose. A1254 treated cells expressed 1.149 ± 0.109 gene expression value (GEV)
compared to 0.761 ± 0.082 GEV for DMSO treated control cells, a 51% increase
(Figure 4.5).

Results of PKC Experiments
To determine whether the effects of A1254 on NF secretion, were exerted via
signaling pathways involving PKC, experiments were performed in the presence of
the PKC hlocker bisindolylmaleimide (bis). Our results show that the effects of
A1254 on GDNF secretion by C6 glial cells were abolished when cultured in the
presence of the PKC inhibitor ( bis) for 24 hours (Figure 4.6).

Discussion
The aim of this study was to investigate whether exposure to PCBs (Aroclor
1254) alters NF expression in C6 glial cells. It was important therefore to determine a
physiologically working dosage that was not fatal to C6 glial cells. It had been shown
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that certain congeners o f PCBs kill cerebellar granule cells within 30 min (Tan et al.
2004).

We exposed C6 cells to A1254 at concentrations ranging from 5ppm to

5Oppm and found that at SOppm, the cells showed signs of compromised health within
30 minutes. Cells exposed to A1254 at lower concentrations of 10 ppm or 20 ppm
showed no visible signs of compromised health for up to several days after exposure.
At 10 ppm, cells proliferated to confluence at the same rate as non-exposed cells and
there was no visible difference between treated and untreated cultures. In addition our
live/dead analysis at 10 ppm A 1254 exposure revealed no difference in mortality of
cells, compared to controls. The results showed that 10 ppm A 1254 increased GDNF
mRNA and protein, as well as NGF protein in cultured C6 cells. The results
confirmed that PCB congeners included in A 1254 preferentially binds small subcellular membranes and organelles such as endoplasmic reticulum (ER) and
ribosomes. It was also determined that PCBs may exert their effect on GDNF in C6
cells via signaling pathways involving PKC.
An experimental exposure level of 10 ppm A 1254 is not unreasonable when
compared to environmental levels. One study showed that composite analysis of
commercial whole fish collected from Lake Ontario found PCB levels of up to 5 ppm
(Johnson 1997). Interestingly the FDA’s previous PCB tolerance level was 5 ppm
(Goldsmith 1979). Moreover, one year after the initial poisoning of the Yu-Cheng
victims (an incident in 1979 where 2,000 people in Yu-Cheng, Taiwan, were exposed
to PCBs from contaminated cooking oil), blood PCB concentrations were up to 1.2
ppm (Masuda 1985). Because PCBs are highly lipophilic, (Korrick et al., 1998) lipid
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tissue burdens can be much higher. For example a Hudson River Report states—
“While it is true that PCB levels have declined over the years, the average PCB
concentrations for all species are still 644 ppm lipid-based PCBs (Ipcb) in the Upper
Hudson and 84 ppm Ipcb in the Lower Hudson, with levels as high as 3285 ppm Ipcb
and 429 ppm Ipcb in Upper and Lower Hudson River fish, respectively” (Clearwater,
2001).

Our results indicate that rat C6 glial cells exposed to 10 ppm A1254 secreted
significantly higher concentrations of NGF and GDNF in the culture medium. We
had hypothesized that PCBs would cause alterations in NF. We initially predicted
however, that such alterations may have been a down regulation of expression, based
on results reported in animal studies. Yet, the glial cells response to the PCBs’ insult
we observed may not be surprising. The roles of glia include support and survival
promotion. Studies have shown that microglial-conditioned media promote neuronal
survival in culture due to neurotrophic factors they produce (Nagata et al. 1993).
GDNF as well as NGF are survival factors for various neurons (Grimm et al. 1998,
Zhou 1994). We saw that glial cells produce and secrete GDNF and NGF in the
presence of A 1254 in vitro. It has been shown that glial cells increase their
production of NF in response to diffusible molecular signals they receive fi’om the
compromised but salvageable neurons they support (Aschner et al. 1999). Our results
show similar response in the absence of such neuronal cues in vitro. This may be an
initial default mode of operation for glial cells when a foreign toxin such as A1254 is
sensed, or it may suggest that congeners within the A1254 mixture can mimic certain
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neuronal chemical ‘help-cues’. PCBs have been reported to have the ability to
directly mimic natural hormones, both as potentially potent and persistent agonists
and antagonists (McKinney and Walter 1994).
We observed dynamic swings in the secretion of GDNF from C6 glial cells
when they were maintained in the same culture for 72 hours, and medium was
sampled at several different time points. As can be seen from the data of figure 4.2,
this changing pattern of secretion with time was regardless of treatment. This is not
unusual; a recent study reported that GDNF exhibits complex pattern o f expression
(Schaar et al., 1993 in (Caumont AS et al. 2006) and such expression is subject to
tight temporal regulation (Caumont AS et al. 2006). Importantly though, despite the
common temporal variation in expression, the A1254 exposed cells exhibited increase
GDNF during all time points.
Measurements of intracellular NGF and GDNF from A 1254 exposed and
vehicle (DMSO) exposed cells showed there was no significant difference between
them. This suggests that in order to maintain increased secretion without a significant
reduction in intracellular concentration, there may be increased production of NF via
gene up-regulation. Up-regulation of the GDNF gene was confirmed by Real Time
RT- analysis. There was significant increase in GDNF mRNA in the A1254 exposed
cells compared to controls. This further supported our finding of increase secreted
GDNF protein in the medium of PCB exposed glial cells.
There is support for PCBs’ ability to regulate transcription by their interaction
with aryl hydrocarbon receptor (AhR) (Beck 1998, Song and Freedman 2005).
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Interestingly we found that A1254 PCBs was most abundantly associated with C6 cell
small sub-cellular organelles such as microsomes, ribosomes and ER. The aSinity of

certain PCB congeners for small sub-cellular organelles was supported by other
studies. One such study reported that PCBs have been demonstrated to mobilize
microsomal Ca^^ by direct interaction with ryanodine receptors localized within
muscle SR and neuronal ER (Wong and Pessah 1996).
We investigated a possible signaling pathway by which PCB may modify
GDNF gene transcription. The activation o f PKC by PCBs is supported by findings
of (Grimm et al. 1998, Kodavanti and Tilson 2000). Interestingly, activation of PKC
has been shown to up-regulate GDNF in glioblastoma cells (Grimm et al. 1998,
Verity et al. 1998). Results of our study indicate that bisindolymaleimide inhibition
of PKC (Coultrap et al. 1999, Martiny-Baron et al. 1993, Toullec et al. 1991) had a
profound effect on GDNF production by C6 cells in-vitro. A1254’s effect on GDNF
was abolished in cells treated with the PKC inhibitor. Moreover, GDNF values for
the groups exposed to the higher dosage of bis, was significantly lower across
treatments compared to the lower dosage and negative groups. This suggests that
PKC signaling pathways and/or possibly PKA or PKG are important for controlling
GDNF expression in general.
It has been demonstrated in this study that PCBs affect NFs that are important
components o f the nervous system. Effects included; debilitating structural changes
to glial cells in vitro at high dosage and significant changes in NF (NGF and GDNF)
expression and secretion at lower doses. It is important to note that some of these
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changes, namely changes in GDNF, are occurring at the gene level and that a pathway
for such gene regulation was demonstrated. The relationship between the effects of
PCBs on NFs and consequent effects on neuroplascity is not known. The findings of
this study therefore may have interesting implications when considering that
numerous studies emphasize the importance of glial cells and neurotrophic factors to
the nervous system, and their possible relationship to neural activities such as learning
and memory.
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Figure: 4.2. Intracellular Distribution of A1254 and DMSO (Vchicle) in C6 Glial
Cells after 24 Hours of Exposure (lOppm A1254 + 0.1% DMSO). The values
indicate ng A1234 or DMSO/g wet weight of, and the percent of the total A1254 or
DMSO associated with, cell membranes and inclusions. There was insignificant
DMSO associated with cell membranes and inclusions, indicating that most DMSO
was in the cytosol. A1254 was found bound to cell fractions. Most of the A1254 was
bound to small cell-inclusions, which will include ribosomes, ER, and microsomes.
The second largest association was with larger cell inclusions, which will include
nuclei and mitochondria. These results show an association of PCBs with large
onganelles which may be consistant with binding to nuclear receptors.
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Figure: 4.3. Effects of A1254 on NGF and GDNF Secretion by C6 Glial Cells in
Culture. Aroclor 1254 induced a significant increase in the secretion of NGF (A) and
GDNF (B) in 06 cells. Cells were exposed to DMSO (0.1%), or DMSO (0.1%) +
PCB (lOppm) for 24 hrs. Results were obtained by ELISA. The data shown represent
the mean ± S.E.M o f values obtained from 5 experiments. The asterisk * represents
significant difference from other groups. One-way ANOVA followed by Dunnette
Post Hoc, P < 0.01
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Figure 4.4. Effects of PCB on Secretion of GDNF from C6 Cells Glial Cells in
Culture at 4 Different Periods of Exposure. Treatment of C6 glial cells with PCB
caused significant increase in GDNF secretion for all time points. Cells cultured in
medium supplemented with 3.5g/L glueose, were treated with DMSO (0.1%) or
DMSO (0.1%) + PCB (lOppm). Data represents the mean ± S.E.M. from 5
experiments. * = significant difference fi"om other groups within the respective
interval. One way ANOVA followed by Dunnett Post Hoc. P< 0.050
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Figure 4.5. The Effect of PCB on GDNF Gene Regulation in Exposed Cultured
C6 Glial Cells. Aroclor 1254 significantly increased the expression of GDNF mRNA
in exposed C6 glial cells. Data shown represents the mean ± S.E.M. of values
obtained from 4 experiments. One-way ANOVA followed by Post Hoc. P < 0.05, * =
significantly > all other groups.
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Figure 4.6. The Effect of Inhibited PKC on the Modification of GDNF hy A1254
in Cultured C6 Glial Cells. The effect of Aroclor 1254 on GDNF secretion (#
group A) was abolished when 0.132 pM bisindolylmaleimide (bis) was added to the
medium in which the cells were cultured for 24 hours (group B). At the much higher
dosage—5.8 pM bis, which at this concentration also blocks PKA and PKG, GDNF
levels were significantly lower (* group C) for A 1254-treated as well as controls,
compared to group A and B. These results: (1) confirm that PKC and possibly PKA
& PKG activation, has strong effects on GDNF, (2) Suggests that A1254 induces its
effect via pathways involving PKC. Statistical test: 1-way ANOVA followed by
Dunnett Post Hoc, P < 0.001. # = sig. diff. within group, * sig. diff. from
corresponding treatment in other groups.
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SUM OF CELLS COUNTED FROM 8 RANDOM VISUAL FIELDS PER EXPERIMENT
DMSO (0.1%)
Aroclor 1254 (lOppm)
TREATMEINT: Control (medium)
Experiment
1
2
3

dead
18
37
11

live
306
1178
1475

%live
94.444
96.955
99.26

dead
35
24
22

live
625
765
1698

Ave. 96.886

% live
94.935
96.958
98.721

dead
76
15
10

live
1529
533
1257

Ave. 96.871

% live
95.265
97.263
99.211

Ave. 97.246

Table 4.1. Comparison of the Live/Dead Ratio of C6 Cells between Treatments.
Results show no significant difference in live/dead ratio between treatments and >
95% live cells were maintained for all groups. Ratio obtained by treatment with
Calcien (for live cell detection) and EthD-1 (for dead). Total live and dead cells were
counted from each of 8 random visual fields from 2 -3 plates per treatment and
averaged.

Treatment

Arocloï 1254
(1 0 p p m )+

0.1%DMSO

Exposure
time
6 hours
3 days
6 hours
3 days

CONTROL/
6 hours
Regular medium
3 days

Mean

±

S.E.

N

P = 0.629

5 Ï 10 ^ ± 2.8 X 10
1 .4 x 1 0

3.4x 10^

3

5.9x10

1.2

1 .3x10

1.2x 10^

P = 0.826
P = 0.475

4 .5 x 1 0 ^ ± 4.9 X 10
1.0 X 10 ® ± 3.4 X 10

Treated compared
to Control

3

P = 0.600

X 10^

3

Table 4.2. Effects of Treatment (lOppm Aroclor or 0.1% DMSO) on
Proliferation of C6 Glial Cells. Cell counts indicated no significant
difference between treatments for either short (6 hr) or long term (72 hr)
exposure time. Cells were seeded at a density of 2.0 x 10^/ml, treated and
allowed to grow for 6 or 72 hours. Statistical analysis: 1-way ANOVA and
Post Hoc, P < 0.05.
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PCB (6hr)
GDNF: 0.11 ± 1.4x10'^

DMSO (6hr)
0.14 ±2.9x10"^

PCB (72hr)
0.19 ±0.14

DMSO (72 hr)
0.24 ±0.17

NGF 0.07 ±4.3x10’^

0.087 ± 5.4x10'^

0.17 ± 6.4x 10'^

0.185 ± 6.8x10'^

Table 4.3 Effects of Aroclor 1254 on Intracellular Concentrations of NGF and
GDNF in C6 Glial Cells in Culture. ELISA was used to determine NGF and GDNF
levels, and neither NGF nor GDNF levels were significantly changed by treatment
with Aroclor 1254 (lOppm) + 0.1% DMSO, compared to treatment with 0.1% DMSO
alone (Student t-test, P < 0.05)
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CHAPTER V
GLOBAL DISCUSSION

The central drive o f the studies of this dissertation were to investigate whether
neurotoxins such as PCBs and lead, can be shown to alter the expression of
neurotrophic factors in brains o f exposed animals and or exposed nervous system
cells. These investigations were prompted by the hypothesis-PCBs affect learning
and memory by altering neurotrophic factor expression and/or effects. The rational
for this line of thinking was based on the many studies supporting the importance of
neurotrophic factors to the genesis, development and maintenance of the nervous
system and components thereof. The supporting literature also established the roles
these factors play in neuronal modifications believed to be the processes required for
learning and memory to occur. It must be understood that except for one
collaborative study in which descriptive correlations were made with spatial learning
and memory (L&M) data, this primary study did not investigate L&M. The
references to, and suggestions about L&M therefore are mostly based on the
assumption that it is generally accepted, that extrinsically induced alterations in
neurotrophic factors are associated with disturbances in cognitive performance.
Most of the reported associations of neurotrophic factors like NGF and BDNF
with deficits in learning and memory, were those of lowered levels, and in some
studies the result of NF gene knockouts. It was not surprising therefore, that our invivo studies of Aroclor 1254 exposed rats revealed, in many cases, significant
reduction of NFs in their brains. It must be noted however, that our argument is about
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significant alterations in NF protein expression that may in turn affect neuronal
processes involved in cognition. That means any significant deviation from normal or
control NF protein levels.
The studies described in Chapter 2 examined NF protein levels in brains from
rats exposed to A 1254 in their diet. It is significant that in most of these experiments
the recurring evidence is that A1254 caused reduced NF expression. It is also
significant that it was not just one NF, but we demonstrated changes in NGF, BDNF
and GDNF.
NF alterations were observed following by both short term and chronic
exposure, although duration o f exposure was shown to influence response. From
observation of control animals, we were able to show that young animals contained
significantly higher levels o f GDNF in their brains than mature animals. This may be
expected since neurological and physiological changes in the brain can be eonsidered
to be more dynamic in the growing youngster than at maturity. Given the functions
described for GDNF, it may be seen why its higher levels are necessary in younger
animals.
Based on our experiments however, both in-vivo and in-vitro, we observed
that expression o f NFs in general seemed to be quite dynamic, with significant
changes oceurring in control as well as treated animals, even within a few hours (as
seen in-vitro). These expression swings seem to continue even during response to
toxic interference. It is very unlikely that these fluctuations are random. On the
contrary, it would be expected that in a living system these fluctuations must be under

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

92
homeostatic control. Changes induced by extrinsic interference to the normal
intrinsic dynamics of the system therefore, would most likely be detrimental.
If a mechanism by which PCBs affect cognitive processes is by indirectly
disturbing NF homeostasis, then the results demonstrated in our studies will be
consistent with our hypothesis. The interpretation of these outcomes in terms of
learning and memory however, would be interesting if we can demonstrate—PCB
exposure, NF reduction and cognitive deficit all in the same group of animals.
Evidence of this combination of events was demonstrated in our collaborative work
with Paris-Larson and her mentor—Baker (Paris-Larson, 2004). In that study, A1254
exposed animals, on an average exhibited higher frequencies o f mistakes in spatial
learning and memory tests and also had average lower levels of NGF, BDNF and
GNDF in their brains.
Armed with the convincing evidence of PCBs’ effect on NF expression in rat
brains a logical next step was to investigate the response of one or more NF to another
known neurotoxin. There are several other environmental pollutants that are known
neurotoxins. Much is known about Pb and its detriment to neural processes and
functions, including learning and memory impairment; especially in children. Pb was
therefore the next chosen candidate of investigation. We became curious about the
possibility, that NFs may be general targets for neurotoxins that affect cognition. It
may have been just a stroke of good luck or ‘instinct’ in that the first choice of
another neurotoxin turned out to be one exhibiting negative correlation to a NF
protein level in rat brains. The effect o f Pb on brain NGF levels was inconclusive but
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its effect on GDNF was significant. GDNF is integral in the support, protection and
maintenance of mid-brain dopaminergic neurons (Barnett et al. 2002, Simon et al.
2001). The finding that Pb affects the expression of GDNF maybe important when
considering Parkinson’s disease, a neural dysfunction associated with lost or
compromised midbrain dopaminergic neurons. (Villadiego et al. 2005).
In the studies on C6 glial cells, we took advantage of the ease of manipulation
offered by in-vitro systems. Here the results were convincing and totally opposite.
C6 glial cells exposed to lOppm A1254 + 0.1% DMSO showed significant increase in
NGF and GDNF expression. Moreover, GDNF mRNA was shown to be upregulated
in exposed cells— indicating that the increase in GDNF protein was due to gene
upregulation. The fact that PCBs are able to upset the homeostasis of regulatory
proteins by gene regulation is significant.
The interesting twist of this story (as it may appear), is that NF expression was
increased by A1254 in glial cells in-vitro while they were decreased in brains of
exposed rats. The apparent contradietion should not be surprising and there are
several possible explanations for it. The roles of glia include support and survival
promotion. Studies have shown that mieroglial-conditioned media promote neuronal
survival in culture due to neurotrophic factors they produce (Nagata et al., 1993).
GDNF as well as NGF are survival factors for various neurons (Grimm et al., 1998;
Zhou et al., 1994). It has been shown that glial cells increase their production of NF in
response to diffiisible molecular signals they receive from the compromised hut
salvageable neurons they support (Aschner et al., 1999). Our results show similar
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response in the absence o f such neuronal cues in vitro. This may be an initial default
mode of operation for glial cells when a foreign toxin such as PCB is sensed, or it
may suggest that congeners within the Aroclor 1254 mixture can mimic certain ‘early’
neuronal chemical ‘help-cues’. PCBs have been reported to have the ability to
directly mimic natural hormones, both as potentially potent and persistent agonists
and antagonists (McKinney et al., 1994).
It is possible that the responses we see in culture are early responses that may
change with chronic exposure or change in method of exposure. In-fact, in
experiments where A 1254 inoculated medium was replaced every 24 hours with fresh
inoculated medium (mimicking daily animal exposure), the trend we observed with
the constant medium over time, was abolished. The longest duration of exposure in
culture was 72 hours, and according to our time-response experiments (chapter IV,
figure 4.4), the largest change (increase) in GDNF by cultured A1254 exposed C6
cells was between the 24*, and 48* hour interval. The shortest exposure for the
animals whose brains we analyzed for NF was 7 days (168 hours).
The conditions in culture are far from being equal to that in the brains. But
even if a similar to in-vitro condition in terms of NF expression, existed in the brain
during the very early stages of exposure, it may have been reversed by the time of our
analysis, due to the overwhelming or exhausting o f the NF protective mechanisms. It
could even be a time when glial cells switch modes in terms of their secretory
products. Researchers suggest that in vivo, either of the two glial ‘modes’;
neurotoxic, to destroy severely damaged neurons or NF-producing to promote

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

95

survival of salvageable ones, is triggered by diffusible molecular signals they receive
jfrom the neurons (Aschner et al., 1999).
In reality, the conditions for glia in culture as apposed to that in the brains (invivo) are too dissimilar for reasonable expectation of similar results in response to a
toxin. Apart from myriads o f compounds in the in-vivo tissue fluids, there are also
several tissue and cell types, and these are in constant dynamic changes, as appose to
a few isolated cells of a pure culture in an essentially static environment, where
secreted and excreted products are accumulative. Furthermore the response we
observed in-vitro was consistent with accounts reported. One study suggested that
once glial cells are isolated and maintained in vitro, the cells exist in a state o f nearmaximal activation, profusely secreting several factors including cytokines and
neurotrophins (Aschner et al., 1999).
Referring to the same 7-days A 1254 exposure in-vivo experiments of chapter
2, the NF response was dose dependent. There was significantly greater effect of
50ppm A1254 compared to lOppm. We don’t know though, how much of the A1254
actually crossed the blood brain barrier and eventually entered brain tissue. The
animals were exposed to A1254 in their food. Here again there is room for significant
difference in dose response when compared to treatment in cell culture.
A consequence of animal exposure to PCBs in their diet is the potential for the
formation of reactive metabolites. For example, it has been shown that PCBs are
metabolized to mono and dihydroxylated compounds by cytochromes P450.
Dihydroxy-PCBs can potentially be oxidized to the corresponding quinones
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(Srinivasan et al. 2001). Metabolites such as quinones create a variety of biological
threats in vivo—including acute cytotoxicity and immunotoxicity (Bolton et al. 2000).
Clearly, PCB metabolites have been implicated in the reduction of endogenously
produced proteins such as hormones in rats. It has been reported that several hepatic
methylsulfonyl-PCB metabolites reduce thyroid hormone levels in rats (Kato et al.
2003). PCB metabolites like those produce by liver activity may have effects on NF
in-vivo, these effects would be absent in culture.
There are 9 glial cells for every one neuron and it’s worth noting that these
two cell types can respond differentially to the same substance. It has been shown
that GDNF is differentially regulated in neuroblastoma and gliobalstoma cell-lines
exposed to the same regulating factor (Verity et al., 1999). The data obtained from
whole brains therefore can be the resultant o f differential responses from the several
tissue subtypes to A1254 and or metabolites.
The departure from normal NF levels was in opposite direction when in-vivo
to in-vitro comparison o f PCB effect was made. This does not diminish the
prediction outlined in the hypothesis of this study. The common effect was significant
disruption of the homeostasis of the NFs that were tested.
Substantial work was done on rat brain sections in this study. Several
experiments involving immunochemistry were conducted on cryostat sections cut
predominantly through hippocampal regions. The hippocampal region was the region
o f choice because of its frequent association with compromised learning and memory
as consequence of its altered NF expression.
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Unfortunately these experiments were not presented in the main study
because of difficulties with inconsistent staining for NFs. Preliminary observations
however, seem to suggest that A1254 can affect the distribution and level of NGF in
rat hippocampal regions. In one experiment, we saw differential staining for NGF
protein in brain sections from control animals compared to animals exposed to 50ppm
A1254. In the section from a control animal a pattern of specific staining of cells was
observed. No specific staining was observed in a similar section from a control
section to which no primary NGF antibody was added. Staining of cells in the section
from the 50ppm A 1254 exposed animals was visibly minimal and the distribution
looked random. A summary o f Immunohistochemistry procedures and preliminary
data are given in the appendix.
We have been able to demonstrate that PCBs significantly alter the
homeostasis of neurotrophic factors, both in-vivo and in-vitro. We also showed that
blood lead levels correlated negatively with brain GDNF protein levels in exposed
rats. We demonstrated an increase in both GDNF mRNA and protein in A1254
exposed glial cells and also discovered a role for PKC in the signal pathway through
which A1254 affected GDNF. We showed down regulation of NGF, BDNF and
GDNF in brains of AI254 exposed rats. Although we did not investigate effects on
NF mRNA in the experimental brains directly, our GDNF level findings from the lead
exposed animals were supported by a recent study which reported reduction of NF
mRMA in hippocampus of rats exposed to lead (Schneider et ah, 2001 in: (Lidsky
and Schneider, 2003). We mentioned numerous studies claiming deficits in learning
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and memory as a consequence of altered NF expression in the CNS (especially brain).
From our collaborative study, there was evidence of correlation between reduced NF
and findings o f reduced spatial learning and memory in rats exposed to PCB. Based
on all this, we speculate that neurotoxins such as PCBs and lead may affect cognition
by their ability to disrupt the homeostasis of NFs important in the process of learning
and memory.
Future studies: Further in-vitro studies may include the co-culture of
neuronal cells with glial cells (Park et al. 2001). At the time when synaptic
connections are made between the two types of cells, the co-culture can then be
exposed to the A 1254. The rational is to try to mimic to some extent, the in-vivo
situation where glia are grown in the presence of neurons. Subsequent analysis of NF
levels of the co-cultures can then be compared to the present study’s findings. In
addition, ICC can be done on the co-culture by using for example, the glial fibrillary
acidic protein (GFAP) marker to identify the glia or nestin, a neurofilament protein to
distinguish the neuronal cells. Effects on NF receptors of the cultures may then be
observed by staining against-for example; GFRa and Trk for GDNF and NGF
respectively.
More experiments such as RT-PCR are suggested to determine mRNA
changes for other NFs other than GDNF, NGF and BDNF. Further pharmacological
experiments can be done to elucidate a more complete pathway by which A 1254 may
be causing effect on GDNF levels in C6 glial cells. And also to determine if a
common pathway is involved for other NFs. It would also be interesting to determine
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if the A1254 effect is still present at lower A1254 concentrations, say for example:
5ppm or Ippm.
We suggest further studies in the in-vivo investigations involving A1254
exposed rats. In this study, the brains on which immunohistochemistry was done
were taken from non-perfused animals. This choice was due to the fact that other
tissues from the experimental animals were needed by our collaborators. These tissues
would have been ruined (for their purposes) by perfusion. Staining for neurotrophic
factors in brain sections is inherently difficult due to their very low tissue levels and
complications with background staining. Here is a direct quote from a renown and
well established corporation in the business of Biotechnology: ‘The neurotrophins
have proved difficult to localize which may be due to masking by, fo r example, their
association with Trk receptors or very low concentrations’ (CHEMICON
INTERNATIONAL). Staining of sections from perfused animals is generally the
more common choice presumably because of greater chances of success. The
suggestion therefore is for the exposure of animals to A 1254 with subsequent
perfusion to prefix brain tissue, before immunohistochemistry for NFs. We suggest
also that blood PCB burden be assayed for each animal for correlation with brain NF
findings.
A greater number of correlative studies where A1254 or Lead exposed animals
with low brain NFs (due to the exposure) can be analyzed for learning and memory
(using different L&M analysis), may serve to verify or reinforce our findings in
further support of our objectives and suggestions.
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Appendix A
Preliminary Immunohistochemical Studies on Rat Brain Sections
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Using Immunohistochemistry to Determine Effects of Aroclor 1254 on
Neurotrophic Factor Expression in the Brains of Exposed Rats

This study was intended to complement the study in chapter 2 that involved
the A1254 exposed rats. This was an attempt to determine whether there were
localized differences in NF occurrence in regions like the cortex and hippocampus.
The idea was to stain the brain sections for NGF, BDNF and GDNF and compare
distribution and staining intensity among the various treatments. The following is an
outline of the brain sectioning and staining procedure used in this study and a
preliminary result obtained.

Rat Brain Sectioning
The complementary (with respect to those used for ELISA) hemispheres of
brains were sectioned on a cryostat (Leica CM 3050) held at-18 °C. Slices were
sectioned at 12 - 16pm for regular light microscopy and 40 - 60pm for fluorescence
staining and confocal microscopy. The brains were sectioned in such a way as to
obtain slices eoronally through the hippocampus region. The sections were allowed
to adhere to cold slides {Fisher Scientific) prior to fixing.

Immunohistochemistry: fLight microscopy)
Microscope slides with brain sections (14 pm) from each of the two treatment
groups and from controls were fixed in ice-eold methanol or acetone for 5-10
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minutes. After 3 washes in PBS, staining procedures were followed according to
protocols adapted fi-om VECTASTAIN (Vector Laboratories, Inc.) with minor
modifications. For GDNF, we used a rabbit anti GDNF polyclonal primary antibody
(D-20, fi-om Santa Cruz Biotechnology, Inc). The secondary antibody was a mouse
anti-rabbit conjugated to biotin, followed by streptavidin conjugated to alkaline
phosphatase. The protocol followed for NGF was the same except that we use a rabbit
anti-NGF polyclonal antibody from CHEMICON International, Inc.

Fluorescence
Slides with brain sections (40pm) from each of the two treatment groups and
fi-om controls were fixed in Zamboni’s fixative for 10-15 minutes. The sections were
washed in PBS (pH 7.4) and were then allowed to air dry for 1 hour. The slides were
then blocked with 3-5% BSA in PBS or 3% serum fi-om the same strain of animal
from which the secondary antibodies were obtained, in 1 % BSA-PBS. Without
washing, excess blocking liquid was blotted away and except for the negative control
slides (which were incubated with blocker instead of 1° antibody) all other slides were
incubated with primary antibody at 4 degrees Celsius for a minimum of 24 hours (on
occasions we incubated for up to 4 days). The slides were washed 3 times and then
incubated for 1 hour with a fluorescence labeled secondary antibody, an Alexafluor
(molecular probes). This final incubation was followed by gentle rinsing and the
slides were cover-slipped with 50% glycerol solution and sealed with nail polish or
rubber cement. The sections were then viewed using a confocal microscope.
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Results
The following photos were obtained from a section o f the rat hippocampus
bound with anti-NGF monoclonal antibody (R&D). Panels A, B and C display images
captured from similar locations in the hippocampal region of the brain. Panel A
shows what appears to be specific staining for NGF in cells of the hippocampus.
Panel B shows a field taken from hippocampus of a rat exposed to SOppm A 1254. In
panel B there appears to be no specific staining for NGF. Panel C shows a section
similar to A but to which no primary antibody against NGF was added. These
preliminary findings suggest that A1254 exposed rat brains show little positive
staining for NGF. Unfortunately, we were unable to repeat these results.
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Anti-NGF Staining in Brain Section from Control Rats: Software generated 8-bit
image @ 20X-- photographed using the Metamorph software. Viewed with a Zeiss
microscope fitted with fluorescence filters.
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B
No Primary (1”) Control—Anti-NGF Stain in Brain Sections from a Non-Exposed
(Negative Control) Rat. Software generated 8-bit image @ 20X—photographed
using the Metamorph software. Viewed with a Zeiss microscope fitted with
fluorescence filters.
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Anti-NGF Stain in Brain Section from a Rat Exposed to A1254 at a Dose of
SOppm. Software generated 8-bit image @ 20X—photographed using
the Metamorph software. Viewed with a Zeiss microscope
fitted with fluorescence filters.
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Appendix B
Recipes of Solutions Used
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(1) Calcium and Magnesium Free Tyrodes:
1. Add 600 ml of cell culture water to a 1 liter beaker.
2. Add 100 ml Stock A.
3. Add 2.2 g/liter of glucose (d-glucose).
4. Add 10 ml HEPES solution (1 M pH=7.4).
5. Add 5 ml of Antibiotic/Antimycotic solution.
6. Bring volume up to approximately 950 ml.
7. Set pH to 7.4.
8. Bring volume up to 1 liter (using volumetric flask).
9. Filter sterilize (0.2 micron filter) into sterile bottle.
10. Store at 4° C.

Stock A Solution.
1. Add the following to a 1000 ml beaker.
a)NaCl 75.03 g/liter.
b)K Cl 2.24 g/liter.
c) NaHCOs 17.22 g/liter.
d) Bring to final volume of 1000 ml using cell culture water.
e) Filter sterilize and store at 4° C.
(2) Phosphate Buffered Saline (PBS).
Final desired volume;

1 liter

1. Initial volume o f distilled water
800ml
2. AddNaCl.
9g
3. Add NaH 2P 0 4 (monobasic).
2.4 g
4. Add Na 2HP0 4 (dibasic).
11.4 g
5. Mix well.
7. Adjust pH to 7.4 using NaOH.
8. Adjust to final volume with distilled water.
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(31 Sample Processing Buffer (SPBl: Wash buffer (PBS + 0.05% tween) +
0.4 M NaCl + 2 mM EOTA. 0.1 mM benzethonium chloride, 2 mM benzamidine, 20
KlU/ml aprotinin, 0.5% BSA.
In wash buffer add 1:100 dilutions of each of the following stock solutions.
- 200 mM EDTA (7.44 g/100 ml WB, pH 8 to dissociate, then set to pH 7.4,
store @ 25° C.
- 10 mM benzethonium chloride (0.448 g/100 ml WB, store @ 25° C.
- 200 mM benzamidine (3.13 g/100 ml WB, store @ 25° C.
Then,
Add 1.42 g NaCl per 100 ml wash buffer.
Add 500 mg BSA per 100 ml of sample buffer.
Add aprotinin (164 pl/lOO ml sample buffer if using Sigma A-6012).
(4) Zamboni’s fixitive recipe
To make 100 ml:
1
2
3
4

25 ml 8% paraformaldehyde
0.15 ml of picric acid
Fill to 100 ml with 0.1 M PB
pH to7.3-7.4
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